fema trailer mdl no. 1873 formaldehyde p - US District Court ...
fema trailer mdl no. 1873 formaldehyde p - US District Court ...
fema trailer mdl no. 1873 formaldehyde p - US District Court ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
UNITED STATES DISTRICT COURT<br />
EASTERN DISTRICT OF LOUISIANA<br />
NEW ORLEANS DIVISION<br />
IN RE: FEMA TRAILER MDL NO. <strong>1873</strong><br />
FORMALDEHYDE<br />
PRODUCT LIABILITY LITIGATION<br />
SECTION “N-5"<br />
THIS DOCUMENT IS RELATED TO:<br />
Lyndon Wright v. Forest River, Inc., et al.<br />
Case No. 09-2977 (E.D. La.)<br />
JUDGE ENGELHARDT<br />
MAG. JUDGE CHASEZ<br />
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *<br />
PLAINTIFF’S EXHIBIT LIST<br />
NOW INTO COURT, through undersigned counsel, comes Plaintiff, Lyndon Wright,<br />
pursuant to this Ho<strong>no</strong>rable <strong>Court</strong>’s August 2009 Trial Scheduling Order, who hereby submits the<br />
following Exhibit List in connection with the above-captioned matter, to be supplemented by<br />
ongoing production, depositions and discovery:<br />
Exhibit<br />
ID<br />
Plaintiff<br />
’s<br />
Exhibits<br />
Government<br />
al Agency<br />
Reports and<br />
Studies<br />
1. CDC Summary and Interim Report:<br />
VOC and Aldehyde Emissions in Four<br />
FEMA Temporary Housing Unites –<br />
Indoor Environment Department,<br />
Lawrence Berkeley National Laboratory,<br />
8 May, 2008<br />
Category: Exhibit Description: Bates Range:<br />
1<br />
PSC002113 –<br />
PSC002166<br />
2. U.S. Department of Health and Human PSC002167 –
Services and CDC Presentation Titled<br />
“Formaldehyde Levels in Occupied<br />
FEMA-supplied Temporary Housing<br />
Units (THUs) in LA and MS, Winter<br />
2007-2008”<br />
3. CDC Interim findings on Formaldehyde<br />
Levels in FEMA-Supplied Travel<br />
Trailers, Park Models, and Mobile<br />
Homes-February 29, 2008<br />
4. Agency for Toxic Substances and<br />
Disease Registry (ATSDR) “Health<br />
Consultations, Formaldehyde Sampling<br />
at FEMA Temporary Housing Units,<br />
Baton Rouge, Louisiana, February 1,<br />
2007<br />
5. ATSDR October 2007 “An Update and<br />
Revision of ATSDR’s February 2007<br />
Health Consultation: Formaldehyde<br />
Sampling of FEMA Temporary-Housing<br />
Trailers Baton Rouge, Louisiana,<br />
September –October 2006”<br />
6. Statement of Harvey E. Johnson, Jr.,<br />
Acting Deputy Administrator and Chief<br />
Operating Officer for FEMA before the<br />
U.S. Senate Subcommittee on State,<br />
Local, and Private Sector Preparedness<br />
and Integration, March 4, 2008<br />
7. Statement of R. David Paulison, FEMA<br />
Administrator, before the U.S. House of<br />
Representatives Committee on Oversight<br />
and Government Reform, July 19, 2007<br />
8. “Formaldehyde Exposure in Homes: A<br />
Reference for State Officials to Use in<br />
Decision-Making” published in March<br />
2008 by the DHHS, CDC, DHS, FEMA<br />
and the EPA<br />
9. U.S. EPA “Indoor Air Quality” Basic<br />
Information for Formaldehyde-Last<br />
updated November 14, 2007<br />
10. “Formaldehyde Levels in FEMA-<br />
Supplied Trailers-Early Findings from<br />
the Centers for Disease Control and<br />
Prevention”<br />
2<br />
PSC002181<br />
PSC002182 –<br />
PSC002202<br />
PSC002264 –<br />
PSC002277<br />
PSC002278 –<br />
PSC002318<br />
PSC003188 –<br />
PSC003198<br />
PSC003199 –<br />
PSC003207<br />
PSC003208 –<br />
PSC003213<br />
PSC003214 –<br />
PSC003217<br />
PSC003218 –<br />
PSC003219<br />
11. ASTM Standard Test Method for PSC021571 –
Determining<br />
Formaldehyde PSC021582<br />
concentrations in Air and Emission<br />
Rates in Wood Products Using a Large<br />
Chamber (2002)<br />
12. Indoor Air Quality and Health in FEMA PSC021583 –<br />
Temporary Housing for Trailer PSC021584<br />
Residents prepared by CDC<br />
13. Trailer Manufacturers and Elevated PSC024251 –<br />
Formaldehyde Levels Majority Staff PSC024277<br />
Analysis, Committee on Oversight and<br />
government Reform, U.S. House of<br />
Representatives dated on July 9, 2008<br />
14. ASHRAE Handbook, 2007: HVAC<br />
Applications, Chapter One: Residences<br />
DUB002101 –<br />
DUB002107<br />
15. Department of Homeland Security, PSC025938 –<br />
Office of Inspector General: FEMA’s PSC026022<br />
Response to Formaldehyde in Trailers<br />
dated June, 2009<br />
16. Majority Staff Report Subcommittee on<br />
Investigations & Oversight – Committee<br />
PSC002070 –<br />
PSC002112<br />
on Science & Tech<strong>no</strong>logy U.S. House of<br />
Representatives, September 2008,<br />
“Toxic Trailers-Toxic Lethargy: How<br />
the Centers for Disease Control and<br />
Prevention Has Failed to Protect the<br />
Public Health”<br />
17. CDC Interim on CDC Study for<br />
Formaldehyde<br />
LWFR-EXP11-000956-<br />
LWFR-EXP11-000976<br />
18. CDC Final Reports on CDC Study for LWFR-EXP11-000889-<br />
Formaldehyde<br />
LWFR-EXP11-000949<br />
19. Lawrence Berkeley Nation Labs report LWFR-EXP11-001569-<br />
on VOCs in Four Trailers<br />
LWFR-EXP11-001629<br />
20. ATSDR Toxicological Profile for LWFR-EXP11-000294-<br />
Formaldehyde<br />
LWFR-EXP11-000761<br />
21. IARC Mo<strong>no</strong>graphs 2004/2009 To be supplemented<br />
22. ASTDR, Minimal Risk Levels (MRLs) To be supplemented<br />
for Hazardous Substances, 2007<br />
http://www.astdr.cdc.gov/mrls/index.htm<br />
l<br />
23. CDC THU Formaldehyde Test Protocol LWFR-EXP 11-000977 –<br />
LWFR-EXP 11-001012<br />
24. NIOSH, EPA, OSHA, etc. re: To be supplemented<br />
Formaldehyde levels<br />
25. CDC, Final Report on Formaldehyde LWFR-EXP 11-00889 –<br />
3
Levels in FEMA-Supplied Travel LWFR-EXP 11-00949<br />
Trailers, Park Models, and Mobile<br />
Homes; Conclusions; 2008,<br />
http://www.cdc.gov/nceh/ehhe/<strong>trailer</strong>stu<br />
dy/residents.htm<br />
Standards,<br />
Regulations,<br />
and Statutes<br />
25 24 C.F.R. § 3280.309, Health Notice on PSC003147<br />
<strong>formaldehyde</strong> emissions Current through<br />
November 6, 2008<br />
26. 24 C.F.R. Parts 3280 and 3285 LWFR-EXP5-000457-<br />
27. §3280.309 – 24 CFR Ch. XX, Health<br />
Notice on Formaldehyde emissions (4-1-<br />
07)<br />
28. ATSDR Formaldehyde Minimal Risk<br />
Levels and Worksheets – Appendix A<br />
29. U.S. Department of Housing and Urban<br />
Development Rules and Regulations<br />
regarding Formaldehyde, 49 FR 31996<br />
30. California air Resources Board’s<br />
(CARB) Standards<br />
31. Occupational Safety and Health<br />
Administration’s (OSHA) Standards for<br />
Formaldehyde<br />
32. American Conference of Governmental<br />
Industrial Hygienists’ (ACGIH)<br />
Standards for Formaldehyde<br />
33. National Institute of Occupational Safety<br />
and Health’s (NIOSH) Standards for<br />
Formaldehyde<br />
4<br />
LWFR-EXP5-000459<br />
PSC021693 –<br />
PSC021694<br />
PSC003158 –<br />
PSC003172<br />
PSC003173 –<br />
PSC003186<br />
PSC021695 –<br />
PSC021753<br />
PSC021754 –<br />
PSC021772<br />
To be supplemented<br />
PSC024278 –<br />
PSC024358<br />
34. NIOSH Pocket Guide LWFR-EXP3-000257<br />
35. Housing and Urban Development’s To be supplemented<br />
(HUD) Standards for Formaldehyde<br />
(including but <strong>no</strong>t limited to 24 C.F.R. §<br />
3280.308)<br />
36. World Health Organization (WHO) and<br />
Health Canada’s Standards for<br />
Formaldehyde<br />
37. American National Standard (ANSI) for<br />
Medium Density Fiberboard dated<br />
February 4, 1994<br />
PSC024359 –<br />
PSC024361<br />
PSC021773 –<br />
PSC021784<br />
38. American National Standard (ANSI) for PSC021785 –
Particleboard dated February 8, 1999<br />
39. ANSI A119.2, NFPA 1192: Standard on<br />
Recreational Vehicles; 2002 Edition<br />
40. ANSI A119.4, NFPA 1194: Standard on<br />
Recreational Vehicle Parks and<br />
Campgrounds; 2002 Edition<br />
41. ANSI/HPVA HP-1; American National<br />
Standard for Hardwood and Decorative<br />
Plywood<br />
42. Toxicological Profile on Formaldehyde<br />
prepared by ATSDR on July 1999<br />
43. Codes and Standards for Recreational<br />
Vehicles ANSI 119.2, NFPA 1192.<br />
44. Any and all standards adopted and/or in<br />
use from 2005 to present by the<br />
Recreational Vehicle Industry<br />
Association (RVIA)<br />
5<br />
PSC021797<br />
DUB002054 –<br />
DUB002100<br />
PSC021798 –<br />
PSC021817<br />
To be supplemented<br />
PSC024362 –<br />
PSC024829<br />
Including, but <strong>no</strong>t limited<br />
to LWFR-EXP5-000460-<br />
LWFR-EXP5-000461<br />
To be supplemented<br />
45. RVIA Standards LWFR-EXP5-000460-<br />
LWFR-EXP5-000461<br />
46. Building Code of the City of New To be supplemented<br />
Orleans, Louisiana<br />
47 2006 International Building Code LWFR-EXP5-000579-<br />
(excerpts)<br />
LWFR-EXP5-000583<br />
48. 2006 International Residential Code LWFR-EXP5-000584-<br />
LWFR-EXP5-000589<br />
49. ASCE 7 To be supplemented<br />
50. ASTM A-36 To be supplemented<br />
51. FEMA Model Travel Trailer To be supplemented<br />
Procurement Specifications<br />
52. Clean Air Act Extension of 1970 To be supplemented<br />
53. Clean Air Act Amendments of 1990 To be supplemented<br />
54. Dometic Brochure LWSR-EXP10-001334-<br />
LWSR-EXP10-001350<br />
55. New Source Performance Standards To be supplemented<br />
(NSPS)<br />
56. National Emissions Standards for To be supplemented<br />
Hazardous Air Pollutants (NESHAP)<br />
57. National Ambient Air Quality Standards To be supplemented<br />
(NAAQS)<br />
58. OSHA Formaldehyde Standards To be supplemented<br />
59. World Health Organization, 2000, Air To be supplemented<br />
Quality Guidelines for Europe; General<br />
Public
60. Suburban Manufacturing Corporation’s To be supplemented<br />
Manufacturer’s Instructions<br />
61. September 1, 2005, Memo from Doug To be supplemented<br />
Gaeddert to Mike Farrell at NACS<br />
62. National Electrical Code; Article 551 To be supplemented<br />
63. NISOH Pocket Guide to Chemical LWFR-EXP3-000257<br />
Hazards, 2005<br />
64. Excerpts from 2005 Hardwood Plywood To be supplemented<br />
Veneer Association “Where to Buy” pp.<br />
78-84<br />
65. Construction Manuals (Manual of Steel LWFR-EXP5-000457-<br />
Construction, Minimum Design Loads, LWFR-EXP5-000459<br />
Timber Construction Manual)<br />
66. <strong>US</strong>EPA, Indoor Air Quality-Basic To be supplemented<br />
Information-Formaldehyde, Washington<br />
DC, 2007<br />
http://epa.gov/iaq/formalde.html<br />
67. <strong>US</strong>DOL, OSHA, OSHA Formaldehyde To be supplemented<br />
Standards,Washington DC, 2008<br />
http://wvvw.osha.gov/SLTC/formaldehy<br />
de/standards.html<br />
68. World Health Organization, Air Quality To be supplemented<br />
Guidelines for Europe-Formaldehyde,<br />
Copenhagen, DE, 2001<br />
http://www.euro.who.int/document/aiq/5<br />
_8<strong>formaldehyde</strong>.pdf<br />
69. Health Canada, Residential Indoor Air To be supplemented<br />
Quality Guideline-Formaldehyde, 2006<br />
http://hc-sc.gc.calewh-selnt/alt<br />
forn1ats/hecssesc/pdf/pubs/air/<strong>formaldehyde</strong>-eng.pdf<br />
70. NIOSH, NIOSH Pocket Guide to<br />
Chemical Hazards, 2005<br />
http://www.cdc/gov/niosh/npg/npgd0293<br />
To be supplemented<br />
.html<br />
71. NIOSH, Method 2016 (Formaldehyde),<br />
Issue 2, NIOSH Manual of Analytical<br />
Methods (NMAM), Fourth Edition, 2003<br />
http://www.cdc.gov/Niosh/nmam/pdfs/2<br />
016.pdf<br />
72. ACGIH, Documentation of Threshold<br />
Limit Values and Biological Exposure<br />
Indices, 2001<br />
6<br />
LWFR-EXP 11-001662 –<br />
LWFR-EXP 11-001668<br />
LWFR-EXP11-000136 –<br />
LWFR-EXP11-000137<br />
73. Singh, Distribution of Selected Gaseous LWFR-EXP11-000138 -
Organic Mutagens and Suspect LWFR-EXP11-000146<br />
Carci<strong>no</strong>gens In Ambient Air<br />
74. ASHRAE – 62.2 Ventilation and<br />
Acceptable Indoor Air Quality in Low<br />
LWFR-EXP11-000147 –<br />
LWFR-EXP11-000222<br />
Rise Residential Buildings<br />
75. AHSRAE Standard 62.1 - 2004 LWFR-EXP11-000223 –<br />
LWFR-EXP11-000224<br />
76. ASTM – 1827 Blower Door LWFR-EXP11-000225 –<br />
LWFR-EXP11-000236<br />
77. ASTM E 1333 LWFR-EXP11-000237 –<br />
LWFR-EXP11-000248<br />
78. ATSDR 2007 Update Report LWRF-EXP11-000253 –<br />
LWFR-EXP11-000293<br />
79. ATSDR 2007 Report FEMA Temporary<br />
Housing Units<br />
LWFR-EXP 11-000772-<br />
LWFR-EXP 11-000785<br />
80. ATSDR Revised Report Baton Rouge LWFR-EXP 11-000786 –<br />
7<br />
LWFR-EXP 11-000826<br />
LWFR-EXP 11-000870 –<br />
LWFR-EXP 11-000883<br />
81. ATSDR Toxicological Profile for<br />
Formaldehyde<br />
82. CTEH Protocol LWFR-EXP 11-001032 –<br />
LWFR-EXP 11-001049<br />
83. Defendants’ Protocol LWFR-EXP 11-001050 –<br />
LWFR-EXP 11-001067<br />
84. Fact Sheet Early Findings LWFR-EXP 11-001193 –<br />
LWFR-EXP 11-001194<br />
85. FEMA Job Hazard Analysis Chart LWFR-EXP 11-001289<br />
86. HCOH in Houston Houses LWFR-EXP 11-001440 –<br />
LWFR-EXP 11-001444<br />
87. HCOH in LA CA Air - Grosjean LWFR-EXP 11-001445 –<br />
LWFR-EXP 11-001453<br />
88. HCOH in Mobil Homes LWFR-EXP 11-001454 –<br />
LWFR-EXP 11-001455<br />
89. HCOH in Urban Air LWFR-EXP 11-001456 –<br />
LWFR-EXP 11-001459<br />
90. Hodgson, VOCs in Indoor Air LWFR-EXP 11-001476 –<br />
LWFR-EXP 11-001506<br />
91. Litelpo, Inhaled HCOH LWFR-EXP 11-001507 –<br />
LWFR-EXP 11-001536<br />
92. LBNL-254E Final Report LWFR-EXP 11-001569 –<br />
LWFR-EXP 11-001629<br />
93. Lemus Study LWFR-EXP 11-001630 –<br />
LWFR-EXP 11-001639<br />
94. Long term Particleboard Emission<br />
Decay Study<br />
LWFR-EXP 11-001640 –<br />
LWFR-EXP 11-001643
95. Any and all Federal, State, Local, and<br />
Industry Regulations and Guidelines<br />
discussed and relied upon by any<br />
Defendant and/or Plaintiff experts in this<br />
matter.<br />
Articles<br />
96. July 20, 2007 “Formaldehyde and<br />
FEMA Trailers” by Lee Shull, Ph.D<br />
97. Maddalena, Randy; Russell, Marion;<br />
Sullivan, Douglas P.; an Apte, Michael<br />
G. “Aldehyde and Other volatile Organic<br />
Chemical Emissions in Four FEMA<br />
Temporary Housing Unites-Final<br />
Report”-Ernest Orlando Lawrence<br />
Berkeley National Laboratory,<br />
November 2008<br />
98. “Effect of Formaldehyde Inhalation on<br />
Hsp70 in Seminiferous Tubules of rat<br />
testes: an immu<strong>no</strong>histochemical study”<br />
by O. Ozen, et al. (2005)<br />
99. “Formaldehyde and Glutaradehyde and<br />
nasal Cytotoxicity: Case Study within<br />
the Context of the 2006 IPCS Human<br />
Framework for the Analysis of a Cancer<br />
Mode of Action for Humans” by D.<br />
McGregor, et al.<br />
100. “Effects of Inhaled Formaldehyde on<br />
Learning and Memory of Mice” by Z.<br />
Lu, et al. (2008)<br />
101. “Low Concentrations of Formaldehyde<br />
induce DNA damage and delay DNA<br />
repair after UV irradiation in Human<br />
Skin Cells” by G. Emri, et al. (2004)<br />
102. National Cancer Institute (NCI): Fact<br />
Sheet: Formaldehyde and Cancer Risk<br />
dated May 7, 2009<br />
103. National Cancer Institute (NCI):<br />
Formaldehyde Exposure among<br />
Industrial Workers is Associated with<br />
Increased Risk of Cancers of the Blood<br />
and Lymphatic System dated May 12,<br />
2009<br />
104. FEMA media release: FEMA Awards<br />
Contracts for Low Emissions Travel<br />
To be supplemented<br />
PSC021640 –<br />
PSC021641<br />
PSC025133 –<br />
PSC025193<br />
PSC021823 –<br />
PSC021829<br />
PSC021830 –<br />
PSC021846<br />
PSC021847 –<br />
PSC021854<br />
PSC021855 –<br />
PSC021866<br />
PSC021867 –<br />
PSC02<strong>1873</strong><br />
PSC026117 –<br />
PSC026118<br />
PSC021876 –<br />
PSC021879<br />
8
Trailers – April 7, 2009 – Release No.<br />
HQ-09-034b<br />
105. FEMA media release: FEMA to<br />
Introduce New Type of Manufactured<br />
Home – Dec. 18, 2008 – Release No.<br />
1791-343<br />
106. Article – “Formaldehyde Exposure in<br />
No<strong>no</strong>ccupational Environments” by K.<br />
Dally, et al.<br />
107. Article – “Formaldehyde-related Health<br />
Complaints of Residents Living in<br />
Mobile and Conventional Homes” by I.<br />
Ritchie, et al.<br />
108. Article – FEMA rolls out new disaster<br />
mobile homes: Formaldehyde levels are<br />
far below those of Hurricane Katrina,<br />
Rita <strong>trailer</strong>s dated 05/14/09<br />
109. Fact Sheet: Airborne Toxic Control<br />
Measure (ATCM) to Reduce<br />
Formaldehyde Emissions from<br />
Composite Wood Products<br />
110. Environmental Health – Formaldehyde<br />
Exposure in Homes: A Reference for<br />
State Officials to Use in Decision-<br />
Making (March 2008)<br />
111. Environmental Health – What you<br />
should k<strong>no</strong>w about Formaldehyde in<br />
Mobile Homes<br />
112. Formaldehyde Levels in FEMA-<br />
Supplied Trailers; Early Findings from<br />
the Centers for Disease Control and<br />
Prevention<br />
113. “Formaldehyde Indoors” by Dr. Stephen<br />
Smulski, April 1987, Progressive<br />
Builder, 12(4):9-11.<br />
114. Boyson, M. “Nasal mucosa in workers<br />
exposed to <strong>formaldehyde</strong>: a pilot study.”<br />
Br J of Ind Med 47:116-121, 1990<br />
115. Edling, C. “Occupational exposure to<br />
<strong>formaldehyde</strong> and histopathological<br />
changes in nasal mucosa.” Br J of Ind<br />
Med 45:761-765, 1988<br />
116. Holmstrom, M. “Histological Changes<br />
in the Nasal Mucosa in Rats after Long-<br />
PSC021880<br />
PSC021881 –<br />
PSC021888<br />
PSC021889 –<br />
PSC021894<br />
PSC021895 –<br />
PSC021896<br />
PSC026119 –<br />
PSC026120<br />
PSC021897 –<br />
PSC021902<br />
PSC021903 –<br />
PSC021906<br />
PSC003218 –<br />
PSC003219<br />
PSC002752 –<br />
PSC002754<br />
PSC002845 –<br />
PSC002853<br />
PSC002854 –<br />
PSC002865<br />
PSC002866 –<br />
PSC002881<br />
9
term Exposure to Formaldehyde and<br />
Wood Dust.” Acta Otolaryngol (Stockh)<br />
108:274-283, 1989<br />
117. Holmstrom, M. “Histological Changes<br />
in the Nasal Mucosa in Persons<br />
Occupationally Exposed to<br />
Formaldehyde Alone and in<br />
Combination with Wood Dust.” Acta<br />
Otolaryngol (Stockh) 107:120-129, 1989<br />
118. Garrett, MH. “Increased risk of allergy<br />
in children due to <strong>formaldehyde</strong><br />
exposure in homes.” Allergy 1999;<br />
54(4):330-7.<br />
119. Jaakkola, JJ. “Asthma, Wheezing, and<br />
Allergies in Russian Schoolchildren in<br />
Relation to New Surface Materials in the<br />
Home.” Am J Public Health<br />
2004;94(4):560-2<br />
120. Platts-Mills, TA. “Indoor allergens and<br />
asthma: Report of the Third<br />
International Workshop.” J Allergy Clin<br />
Immu<strong>no</strong>l 1997;100(6 Pt 1):S2-S24.<br />
121. “Legacy of Shame: The On-Going<br />
Public Health Disaster of Children<br />
Struggling in Post-Katrina Louisiana.”<br />
Children’s Health Fund & Columbia<br />
Univ. Mailman School of Public Health,<br />
Nov. 4, 2008<br />
122. “Children from FEMA <strong>trailer</strong> park battle<br />
serious health problems” <strong>US</strong>A Today<br />
11/24/08<br />
123. Wantke, F, “Exposure to gaseous<br />
<strong>formaldehyde</strong> induces IgE-mediated<br />
sensitization to <strong>formaldehyde</strong> in schoolchildren”<br />
Clinical and Experimental<br />
Allergy, 1996, Vol. 26, pages 276-280<br />
124. Krzyza<strong>no</strong>wski, Michal, “Chronic<br />
Respiratory Effects of Indoor<br />
Formaldehyde Exposure” Environmental<br />
Research 52, 117-125 (1990)<br />
125. “Indoor Residential Chemical Emissions<br />
as Risk Factor for Children’s<br />
Respiratory Health” by M. Mendell<br />
10<br />
PSC002882 –<br />
PSC002893<br />
PSC002898 –<br />
PSC002905<br />
PSC002906 –<br />
PSC002909<br />
PSC002909 –<br />
PSC002931<br />
PSC006033 –<br />
PSC006052<br />
PSC006053 –<br />
PSC006054<br />
PSC006055 –<br />
PSC006059<br />
PSC006060 –<br />
PSC006068<br />
PSC022228 –<br />
PSC022267<br />
126. “Formaldehyde and Leukemia: PSC026121 –
Epidemiology, Potential Mechanisms,<br />
and Implications for Risk Assessment”<br />
by Zhang, et al.<br />
127. “Formaldehyde-releasers: relationship to<br />
<strong>formaldehyde</strong> contact allergy. Contact<br />
allergy to <strong>formaldehyde</strong> and inventory of<br />
<strong>formaldehyde</strong>-releasers” by Groot, et al.<br />
128. “Prospective study of clinical symptoms<br />
and skin test reactions in medical<br />
students exposed to <strong>formaldehyde</strong> gas”<br />
by Takahashi, et al.<br />
129. “Influence of airborne nitrogen dioxide<br />
or <strong>formaldehyde</strong> on parameters of skin<br />
function and cellular activation in<br />
patients with atopic eczema and control<br />
subjects” by Eberlein-Konig, et al.<br />
130. Zinn, T.,D., Cline and W. Lehmann,<br />
Long Term Study of Formaldehyde<br />
Emission Decay from Particleboard,<br />
Forest Products Journal, June 1990.<br />
131. 2007 An Update and Revision of<br />
ATSDR’S February 2007 Health<br />
Consultation: Formaldehyde Sampling<br />
of FEMA Temporary-Housing Trailers<br />
Baton Rouge, Louisiana, September-<br />
October, 2006. U.S. Department of<br />
Health and Human Services Public<br />
Health Agency for Toxic Substances and<br />
Disease Registry. Atlanta Georgia.<br />
132. 2004. ANSI/HPVA Hp-1-2004<br />
American National Standard for<br />
Hardwood and Decorative Plywood.<br />
HPVA. Reston, Virginia.<br />
133. 1986. From Start to Finish<br />
Particleboard. National Particleboard<br />
Association. Gaithersburg, Maryland.<br />
134. 1986. From Start to Finish Medium<br />
Density Fiberboard. National<br />
Particleboard<br />
Association.<br />
Gaithersburg, Maryland.<br />
135. 2003. VOC Emission Barrier Effect of<br />
Laminates, Overlays and Coatings for<br />
Particleboard, Medium Density<br />
Fiberboard (MDF) and hardboard.<br />
PSC026131<br />
PSC026132 –<br />
PSC026154<br />
JAMES-008350<br />
JAMES-008356<br />
JAMES-008357<br />
JAMES-008359<br />
To be supplemented<br />
LWFR-EXP11-000253-<br />
LWFR-EXP11-000293<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
11
Composite Panel Association.<br />
Gaithersburg, Maryland.<br />
136. Barry, A. and D. Corneau. 2006.<br />
Effectiveness of barriers to minimize<br />
VOC emissions including <strong>formaldehyde</strong>.<br />
Forest Products Journal. 56(9):38-42<br />
137. Groah, W., G. Gramp and M. Trant.<br />
1984. Effect of a decorative vinyl<br />
overlay on <strong>formaldehyde</strong> emissions.<br />
Forest Products Journal 34(4):27-29.<br />
138. J. Thompson, et al., “Malingering” in<br />
Textbook of Forensic Psychiatry (2004),<br />
p. 427-449<br />
139. Seattle Times Op-Ed, June 6, 1980, A-7,<br />
“Formaldehyde Not Dangerous”<br />
140. Paustenbach, Dennis, Corporate<br />
Occupational Exposure Limits the<br />
Current State of Affairs, AIHA Journal,<br />
1986<br />
141. Atchison, J. and Brown, J., The<br />
Log<strong>no</strong>rmal Distribution, Cambridge<br />
University Press, 1957<br />
142. William H. Bullock, et al., A Strategy for<br />
Assessing and managing Occupational<br />
Exposures, AIHA (2006) (excerpts)<br />
143. Esman, et al, Log-Normality of<br />
Environmental Sampling Data, Journal<br />
of Environmental Science and Health<br />
(1977)<br />
144. Falk, Eric K., A Short Explanation of<br />
Retrospective Exposure Assessment and<br />
its Use in Toxic Tort Litigation, Toxic<br />
Torts and Environmental Law<br />
Committee Newsletter (Winter 2009)<br />
145. Gibbons and Coleman, Statistical<br />
Methods for Detection and<br />
Quantification of Environmental<br />
Contamination (2001)<br />
146. Glibert, Richard O., Statistical Methods<br />
for Environmental Pollution Monitoring<br />
(excerpts) (1987)<br />
147. Hewett, Paul, Mean Testing: II.<br />
Comparison of Several Alternative<br />
Procedures, Applied Occupational and<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
LWFR-GEN-000081<br />
LWFR-EXP3-000071-<br />
LWFR-EXP3-000080<br />
LWFR-EXP3-000081-<br />
LWFR-EXP3-000086<br />
LWFR-EXP3-000087-<br />
LWFR-EXP3-000099<br />
LWFR-EXP3-000100-<br />
LWFR-EXP3-000112<br />
LWFR-EXP3-000113-<br />
LWFR-EXP3-000114<br />
LWFR-EXP3-000115-<br />
LWFR-EXP3-000122<br />
LWFR-EXP3-000123-<br />
LWFR-EXP3-000129<br />
LWFR-EXP3-000130-<br />
LWFR-EXP3-000138<br />
12
Environmental Hygiene (1997)<br />
148. Hewett, Paul, “Chapter 16. Industrial<br />
Hygiene Exposure Assessment – Data<br />
Analysis and Interpretation”, from<br />
Handbook of Chemical Safety and<br />
Health (2001)<br />
149. Hodgson, et al., Volatile Organic<br />
compound Concentrations and Emission<br />
Rates in New Manufactured and Site-<br />
Built Homes, Indoor Air (2000)<br />
150. Land, C.E., Tables of Confidence Limits<br />
for Linear Functions of the Normal<br />
Mean and Variance, American<br />
Mathematical Society (1975)<br />
151. Nielsen, et al., Chemical and Biological<br />
Evaluation of Building Material<br />
Emissions, Indoor Air (1997)<br />
152. Paustenbach, Dennie, Occupational<br />
Exposure Limits, Pharmacokinetics, and<br />
Unusual Work Schedules (Chapter 7)<br />
(1994)<br />
153. Suta, Benjamin, Population Exposures<br />
to Atmospheric Formaldehyde Inside<br />
Residences, report to EPA (1980)<br />
154. Versar Final Report: “Formaldehyde<br />
Exposure Model – Description and<br />
Demonstration” (1986)<br />
155. Viet, et al., Guideline on Occupational<br />
Exposure Reconstruction, AIHA<br />
Guideline 11-2008<br />
156. White, et al., Principles of Exposure<br />
Measurement in Epidemiology,<br />
(excerpts) Oxford University Press<br />
(2008)<br />
157. Helena Ribeiro, Sugar Cane Burning in<br />
Brazil: Respiratory Health Effects, Rev.<br />
Saude Publica Vol. 42 <strong>no</strong>.2 Sao Paulo<br />
Apr. 2008 Epub February 29, 2008<br />
158. Lewis, Sax’s Dangerous Properties of<br />
Industrial Materials Tenth Edition and<br />
Hawley’s Condensed Chemical<br />
Dictionary Thirteenth Edition, Wiley,<br />
Hoboken, NJ, 2000.<br />
13<br />
LWFR-EXP3-000139-<br />
LWFR-EXP3-000169<br />
LWFR-EXP3-000217-<br />
LWFR-EXP3-000232<br />
LWFR-EXP3-000233-<br />
LWFR-EXP3-000239<br />
LWFR-EXP3-000241-<br />
LWFR-EXP3-000256<br />
LWFR-EXP3-000258-<br />
LWFR-EXP3-000259<br />
LWFR-EXP3-000260-<br />
LWFR-EXP3-000272<br />
LWFR-EXP3-000279-<br />
LWFR-EXP3000272<br />
LWFR-EXP3-000280-<br />
LWFR-EXP3-000285<br />
LWFR-EXP3-000286-<br />
LWFR-EXP3-000290<br />
LWFR-EXP7-009919-<br />
LWFR-EXP7-009926<br />
To be supplemented<br />
159. California EPA, ARB, Indoor Air To be supplemented
Quality Guideline-Formaldehyde in the<br />
Home, 2004<br />
http://www.arb.ca.gov/researchiindoor/f<br />
ormaldg108-04.pdf<br />
160. Formaldehyde Sampling: Active and<br />
Passive Sampling Protocols, DeVany,<br />
2008<br />
161. AIHA, AIHA Field Guide for<br />
Determination of Biological<br />
Contaminants , Second Edition, 2005<br />
162. Casset A, Purohit A, Marchand C, et al.:<br />
“The Bronchial response to inhaled<br />
<strong>formaldehyde</strong>”<br />
163. Dingle P; “Formaldehyde in Occupied<br />
and U<strong>no</strong>ccupied Caravans in Australia”<br />
164. Songul Acar Vaizoglu; “Determining<br />
Domestic Formaldehyde Levels in<br />
Ankara, Turkey”<br />
165. Fenna A Ebbens, MD, MSc; “The Mold<br />
Conundrum in Chronic Rhi<strong>no</strong>sinusitis:<br />
Where Do We Stand Today?”<br />
166. American College of Occupational and<br />
Environmental Medicine “Adverse<br />
Human Health Effects Associated with<br />
Molds in the Indoor Environment”<br />
167. Affidavit of Patricia M. Williams, PH.D.<br />
D.A..B.T. in the Trial of Alana<br />
Alexander And Christopher Cooper<br />
168. Allenby CF, Basketter DA; “The effect<br />
of repeated open exposure to low levels<br />
of nickel on compromised hand skin of<br />
nickel-allergic subjects”<br />
14<br />
To be supplemented<br />
To be supplemented<br />
LWFR-EXP15-000131-<br />
LWFR-EXP15-000141<br />
LWFR-EXP15-000142-<br />
LWFR-EXP15-000147<br />
LWFR-EXP15-000148-<br />
LWFR-EXP15-000155<br />
LWFR-EXP15-000156-<br />
LWFR-EXP15-000164<br />
LWFR-EXP15-000209-<br />
LWFR-EXP15-000222<br />
LWFR-EXP15-000223-<br />
LWFR-EXP15-000264<br />
LWFR-EXP15-000165-<br />
LWFR-EXP15-000169<br />
169. Allergen Patch Test-Information of<br />
Patients<br />
LWFR-EXP15-000265-<br />
LWFR-EXP15-000303<br />
170. Allergen Patch Test-TRUE test LWFR-EXP15-000304-<br />
LWFR-EXP15-000345<br />
171. D. Sciandra, F. Dispenza, R. Porcasi. G.<br />
Kulamarva, C. Saraniti,<br />
Otorhi<strong>no</strong>laryngology Department;<br />
Human Pathology Department,<br />
University of Palermo, Italy; ENT<br />
Clinic, Nayak’s Road, Kasaragod, India<br />
“Pleomorphic ade<strong>no</strong>ma of the lateral<br />
nasal wall: case report”<br />
LWFR-EXP15-000170-<br />
LWFR-EXP15-000173
172. Josje H. E. Arts, Carolien Mommers,<br />
and Cees de Heer “Dose-Response<br />
Relationships and Threshold Levels in<br />
Skin and Respiratory Allergy”<br />
173. Ralph J Delfi<strong>no</strong>, Henry Gong, Jr.,<br />
William S. Linn, Edo D. Pellizzari, and<br />
Ye Hu “Asthma Symptoms in Hispanic<br />
Children and Daily Ambient Exposures<br />
to Toxic and Criteria Air Pollutants”<br />
15<br />
LWFR-EXP15-000174-<br />
LWFR-EXP15-000208<br />
LWFR-EXP15-000346-<br />
LWFR-EXP15-000356<br />
174. Author Reply; Comment LWFR-EXP15-000357-<br />
LWFR-EXP15-000359<br />
175. M.A. Anderson, M. Nikulin, U. Koljalg,<br />
M. Anderson, F. Rainey, K. Reijula, E. –<br />
L Hintikka, and M. Salki<strong>no</strong>ja-Salonen<br />
“Bacteria, Molds, and Toxins in Water-<br />
Damaged Building Materials”<br />
LWFR-EXP15-000360-<br />
LWFR-EXP15-000366<br />
176. Bender, J; “The use of <strong>no</strong>ncancer<br />
endpoints as a basis for establishing a<br />
reference concentration for<br />
<strong>formaldehyde</strong>”<br />
178. Hodgson, Michael J. Md, MPH; Morey,<br />
Philip, PhD; Leung, Wing-Yan, BS;<br />
Morrow, Lisa PhD; Miller, David, PhD;<br />
Jarvis, Bruce, PhD; Robbins, Howard,<br />
MD;<br />
Halsey, John F. PhD; Storey, Eileen,<br />
MD, MPH; “Building-Associated<br />
Pulmonary Disease from Exposure to<br />
Stachbotrys chartarum and Apsergillus<br />
versicolor”<br />
179. Stuart M. Brooks, Wil Spaul and James<br />
D. McCluskey “The Spectrum of<br />
Building-Related Airway Disorders”<br />
180. J.H Olsen, L. Dragstead & H. Autrup<br />
“Cancer Risk and occupational exposure<br />
to aflatoxins in Denmark”<br />
181. CDC Update “Pulmonary<br />
Hemorrhage/Hemosiderosis among<br />
Infants—Cleveland, Ohio, 1993-1996”<br />
January 17, 1997/46 (02); 33-35<br />
LWFR-EXP15-000367-<br />
LWFR-EXP15-000376<br />
177. Bissett, Drobatz, McKnight, Degernes;<br />
“Prevalence, clinical features, and causes<br />
of epistaxes in dogs”; 176 cases (1996-<br />
2001)<br />
LWFR-EXP15-000377-<br />
LWFR-EXP15-000385<br />
LWFR-EXP15-000386-<br />
LWFR-EXP15-000395<br />
LWFR-EXP15-000396-<br />
LWFR-EXP15-000405<br />
LWFR-EXP15-000406-<br />
LWFR-EXP15-000409<br />
LWFR-EXP15-000410-<br />
LWFR-EXP15-000412
182. CDC Update “Pulmonary<br />
Hemorrhage/Hemosiderosis among<br />
Infants—Cleveland, Ohio, 1993-1996”<br />
March 10, 2000-49 (09); 180-4<br />
183. Chalyasate, Roongrotwattansairi,<br />
Fooanan, Sumitsawan; “Epistaxis in<br />
Chiang Mai University Hospital”<br />
184. Chang “Contact Dermatitis<br />
1997:37:309”<br />
LWFR-EXP15-000413-<br />
LWFR-EXP15-000421<br />
LWFR-EXP15-000422-<br />
LWFR-EXP15-000427<br />
LWFR-EXP15-000428-<br />
LWFR-EXP15-000431<br />
185. Clement PA, Stoot AP, Kaufman L; the<br />
“Influence of <strong>formaldehyde</strong> on the nasal<br />
mucosa”<br />
186. Clinical and Pathogenic Microbiology<br />
(Second Edition)<br />
187. Pierre Auger, MD, Pierre Gourdeau,<br />
MD, and J. David Miller, PhD “Clinical<br />
Experience with Patients Suffering from<br />
a Chronic Fatigue-Like Syndrome and<br />
Repeated Upper Respiratory Infections<br />
in Relation to Airborne Molds”<br />
188. Torkel Fischer, Klaus Anderson, Ulla<br />
Bengtsson, Peter Frosch, Yen<br />
Gunnarssan, Bo Kreilgard, Torkil<br />
Menne, Stephanie Shaw, Louise<br />
Svennson, John Wilkinson “Clinical<br />
Standardization of the TRUE Test<br />
Formaldehyde Patch”<br />
189. Clinical Toxicology-Stachybotrys<br />
Revisited<br />
190. Douglas H. Linz, MD, MS; Susan M.<br />
Pinney, PhD; James D. Keller, MD, MS;<br />
Michael White, MS; C. Ralph Buncher,<br />
ScD; “Cluster Analysis Applied to<br />
Building-Related Illness”<br />
191. Code of Federal Regulations-29-Part<br />
1910-July 1990<br />
192. Luis M. de la Maza, M.D., Ph.D., Marie<br />
T. Pezzlo, M.A (AAM); Ellen Jo Baron.,<br />
F (AAM) “Color Atlas of Diag<strong>no</strong>stic<br />
Microbiology”<br />
193. Comment, Comment ILL Number:<br />
55546440<br />
16<br />
LWFR-EXP15-000432-<br />
LWFR-EXP15-000438<br />
LWFR-EXP15-000439-<br />
LWFR-EXP15-000440<br />
LWFR-EXP15-000441-<br />
LWFR-EXP15-000442<br />
LWFR-EXP15-000443-<br />
LWFR-EXP15-000449<br />
LWFR-EXP15-000450-<br />
LWFR-EXP15-000452<br />
LWFR-EXP15-000453-<br />
LWFR-EXP15-000459<br />
LWFR-EXP15-000460-<br />
LWFR-EXP15-000461<br />
LWFR-EXP15-000462-<br />
LWFR-EXP15-000463<br />
LWFR-EXP15-000464-<br />
LWFR-EXP15-000466<br />
194. P. Sherwood Burge, A.S Robertson, and LWFR-EXP15-000467-
A.Hedge “Comparison of Self-<br />
Administered Questionnaire with<br />
Physician Diag<strong>no</strong>sis in the Diag<strong>no</strong>sis of<br />
the Sick Building Syndrome”<br />
195. J.M Fernandez Vozmedia<strong>no</strong> and J.C<br />
Armario Hita “Concordance and<br />
discordance between TRUE Test and<br />
Finn Chamber”<br />
196. S. Iris Ale and Howard I. Maibach<br />
“Reproducibility of patch test results: a<br />
concurrent right-versus-left study using<br />
TRUE Test”<br />
197. Daele, Vander, Poorten, Rombaux,<br />
Hamoir; “Cancer of the nasal vestibule,<br />
nasal cavity and paranasal sinuses”<br />
198. Robert Dales MD MSc(Epid), Ling Liu<br />
MMD PhD, Amanda J. Wheeler PhD,<br />
Nicolas L. Gilbert MSc “Quality of<br />
indoor residential air and health”<br />
199. B. Brunekreef “Damp housing and adult<br />
respiratory symptoms”<br />
200. Chih-Shan Li, Ching-Wan HSU, Chia-<br />
Hui Lu “Dampness and Respiratory<br />
Symptoms among workers in Daycare<br />
Centers in a Subtropical Climate”<br />
201. T.L Brasel, D.R Douglas, S.C Wilson,<br />
and D.C Straus “Detection of Airborne<br />
Stachybotrys chartarum Macrocyclic<br />
Trichothecene Mycotoxins on<br />
Particulates Smaller than Conidia”<br />
202. Louise Arup Fischer, Torkil Menne, and<br />
Jeanne Duus Johansen “Dose per unit<br />
area-a study of elicitation of nickel<br />
allergy”<br />
203. Druce HM; “Nasal provocation<br />
challenge-strategies for experimental<br />
design”<br />
204. Paul Ar<strong>no</strong>w, M.D; Jordan Fink, M.D.;<br />
Donald Schleuter, M.D.; Joseph<br />
Barboriak, Sc.D.;<br />
George Mallison, M.P.H; Sami Said,<br />
M.D; Stanley Martin, M.S.; George<br />
Unger, M.D; Gerald Scanlon, M.D;<br />
Viswanath Kurup, Ph.D.; “Early<br />
LWFR-EXP15-000470<br />
LWFR-EXP15-000471-<br />
LWFR-EXP15-000472<br />
LWFR-EXP15-000473-<br />
LWFR-EXP15-000482<br />
LWFR-EXP15-000483-<br />
LWFR-EXP15-000493<br />
LWFR-EXP15-000494-<br />
LWFR-EXP15-000499<br />
LWFR-EXP15-000500-<br />
LWFR-EXP15-000504<br />
LWFR-EXP15-000505-<br />
LWFR-EXP15-000508<br />
LWFR-EXP15-000509-<br />
LWFR-EXP15-000517<br />
LWFR-EXP15-000523-<br />
LWFR-EXP15-000529<br />
LWFR-EXP15-000530-<br />
LWFR-EXP15-000536<br />
LWFR-EXP15-000537-<br />
LWFR-EXP15-000543<br />
17
Detection of Hypersensitivity<br />
Pneumonitis in Office Workers”<br />
205. Fenna A Ebbens, Christos Georgalas and<br />
Wytske J. Fokkens “Fungus as the cause<br />
of chronic rhi<strong>no</strong>sinusitis: the case<br />
remains unproven”<br />
206. Fenna A Ebbens, MD, MSc, and Wytske<br />
J. Fokkens, MD, PhD “The Mold<br />
Conundrum in Chronic Rho<strong>no</strong>sinusitis:<br />
Where Do We Stand Today?”<br />
207. Mario Nikulin, Kari Reijula, Bruce<br />
Jarvis, Pirio Veijalanien and Eeva-Liisa<br />
Hintikka<br />
“Effects of Intranasal Exp to Spores of<br />
Stachybotrys Atria in Mice”<br />
208. Noreen N. Khan and Bobby Wilson<br />
“Environmental Assessment of Mold<br />
Concentrations and Potential Mycotoxin<br />
in the Greater Southeast Texas Area”<br />
209. U.S Environmental Protection Agency<br />
“EPA Fine Particle PM 2.5<br />
Designations”<br />
18<br />
LWFR-EXP15-000544-<br />
LWFR-EXP15-000550<br />
LWFR-EXP15-000551-<br />
LWFR-EXP15-000559<br />
LWFR-EXP15-000560-<br />
LWFR-EXP15-000566<br />
LWFR-EXP15-000567-<br />
LWFR-EXP15-000581<br />
LWFR-EXP15-000582-<br />
LWFR-EXP15-000604<br />
210. EPA Safe Contaminent Chart LWFR-EXP15-000605-<br />
LWFR-EXP15-000610<br />
211. M. Lei<strong>no</strong>, M. Makela, K. Reijula, T.<br />
Haahtlat, H. Mussalo-Rauhamaa, T.<br />
Toumi, E-L Hintikka, and H. Alenius<br />
“Intranasal exposure to a damp building<br />
mould, Stachybotrys chartarum, induces<br />
lung inflammation in mice by satraxinindependent<br />
mechanisms”<br />
LWFR-EXP15-000611-<br />
LWFR-EXP15-000618<br />
212. Claus Zachariae, Barbara Hall, Martine<br />
Cottin, Sylve Cupferman, Klaus<br />
Andersen, T. Menne “Experimental<br />
elicitation of contact allergy from a<br />
diazolidinyl uera-preserved cream in<br />
relation to anatomical region, exposure<br />
time and concentration”<br />
213. Marjo Nikulin, Kari Reijula, Bruce B<br />
Jarvis, and Eeva-Liisa Hintikka<br />
“Experimental Lung Mycotoxicosis in<br />
Mice Induced by Stachybotrys Atra”<br />
214. L.A. Fischer, J.D Johnson, and T. Menne<br />
“Methyldibromoglutaronitrile allergy:<br />
LWFR-EXP15-000619-<br />
LWFR-EXP15-000629<br />
LWFR-EXP15-000630-<br />
LWFR-EXP15-000634<br />
LWFR-EXP15-000635-<br />
LWFR-EXP15-000641
elationship between patch test and<br />
repeated open application test<br />
thresholds”<br />
215. Lawrence Fishbein, PhD “Exposure<br />
from occupational versus other sources”<br />
216. Floods Carry Potential for Toxic Mold<br />
Disease; May 1997<br />
217. Flyvholm MA, Hall BM, et al;<br />
Threshold for occluded <strong>formaldehyde</strong><br />
patch test in <strong>formaldehyde</strong>-sensitive<br />
patients. Relationship to repeated open<br />
applica”<br />
218. Peter Franklin, Peter Dingle, and<br />
Stephen Stick “Raised Exhaled Nitric<br />
Oxide in Healthy Children is Associated<br />
with Domestic Formaldehyde Levels”<br />
219. Karl E. Frees, et al “Severe complication<br />
after administration if formalin for<br />
treatment of progressive ethomidal<br />
hematoma in a horse”.<br />
220. Kazuyasu Fujii, et al “Effect of<br />
<strong>formaldehyde</strong> Gas Exposure in a Marine<br />
Allergic Contact Hypersensitivity<br />
Model”<br />
221. Fran Fisher., M.T. (ASCP), et al<br />
“Fundamentals of Diag<strong>no</strong>stic<br />
Mycology”<br />
19<br />
LWFR-EXP15-000642-<br />
LWFR-EXP15-000654<br />
LWFR-EXP15-000655-<br />
LWFR-EXP15-000656<br />
LWFR-EXP15-000657-<br />
LWFR-EXP15-000665<br />
LWFR-EXP15-000666-<br />
LWFR-EXP15-000668<br />
LWFR-EXP15-000669-<br />
LWFR-EXP15-000670<br />
LWFR-EXP15-000671-<br />
LWFR-EXP15-000684<br />
LWFR-EXP15-000685-<br />
LWFR-EXP15-000686<br />
222. James Gibson “Formaldehyde Toxicity” LWFR-EXP15-002177-<br />
LWFR-EXP15-002178<br />
223. Gollhausen Rainer, et al<br />
“Reproducibility of patch test results;<br />
Comparison of TRUE Test and Finn<br />
Chamber Test Results”<br />
LWFR-EXP15-000687-<br />
LWFR-EXP15-000691<br />
224. Gottschalk C, Bauer J, Meyer K.;<br />
“Detection of Satratoxin G and H Indoor<br />
Air from a Water-Damaged Building”<br />
225. Gutarowska B, Wiszniewska M, et al;<br />
“Exposure to moulds in flats and the<br />
prevalence of allergic diseasespreliminary<br />
study”<br />
LWFR-EXP15-000692-<br />
LWFR-EXP15-000697<br />
LWFR-EXP15-000698-<br />
LWFR-EXP15-000706<br />
226. Unk<strong>no</strong>wn, Erratum LWFR-EXP15-000707-<br />
LWFR-EXP15-000708<br />
227. R.W Hanckel, M.D., and Richard Carter,<br />
M.D.; “Epistaxis”<br />
LWFR-EXP15-000709-<br />
LWFR-EXP15-000714
228. Haraguchi, Ebihara, Saikawa, et al;<br />
“Malignant tumors of the nasal cavity;<br />
review of a 60-case series”<br />
229. Hata, H, Taka<strong>no</strong> H, Matsumiya G., et al;<br />
“Late complications of gelatin-resorcinformalin<br />
glue in the repair of acute type<br />
A aortic dissection”<br />
230. Jun-ichi Hattori, MD, et al;<br />
“Bronchospasm Induced by Propofol in<br />
a Patient with Sick House Syndrome”<br />
20<br />
LWFR-EXP15-000715-<br />
LWFR-EXP15-000723<br />
LWFR-EXP15-000724-<br />
LWFR-EXP15-000731<br />
LWFR-EXP15-000732-<br />
LWFR-EXP15-000733<br />
231. Hazard Communication LWFR-EXP15-000734-<br />
LWFR-EXP15-000756<br />
232. Eckardt Johanning, et al; “Health and<br />
Immu<strong>no</strong>logy study following exposure<br />
to toxigenic fungi (Stachybotrys<br />
chartarum) in a water damaged office<br />
environment”<br />
LWFR-EXP15-000757-<br />
LWFR-EXP15-000768<br />
233. Peter Kozak Jr.; “Home Mold Surveys” LWFR-EXP15-000769-<br />
LWFR-EXP15-000778<br />
234. IARC Vol 100 F- A review of human LWFR-EXP 15-000779<br />
carci<strong>no</strong>gens Part F<br />
235. Imidazolidinyl Urea 39236-46-9 LWFR-EXP15-000780-<br />
LWFR-EXP15-000797<br />
236. Immu<strong>no</strong>logy 7th Edition -<br />
Hypersensitivity Type IV - Chapter 26<br />
LWFR-EXP15-000798-<br />
LWFR-EXP15-000800<br />
237. Dales, Robert, et al; “ndoor Air Quality<br />
and Health; Reproducibility of<br />
Respiratory Symptoms and Reported<br />
Home Dampness and Molds using a<br />
Self-Administered Questionnaire”<br />
LWFR-EXP15-000801-<br />
LWFR-EXP15-000806<br />
238. D.M Kuhn and M.A Ghan<strong>no</strong>um “Indoor<br />
Mold, Toxigenic Fungi, and<br />
Stachybotrys Charatarum: Infectious<br />
Disease Perspective”<br />
239. Ana Rask-Anderson, et al; “Inhalation<br />
Fever and Respiratory Symptoms in<br />
Swedish Sawmills”<br />
240. Izulani H. Shibukawa, et al; Devasting<br />
late complication for repair of type A<br />
Acute aortic dissection with usage of<br />
gelatin-resorci<strong>no</strong>l-formalin glue”<br />
241. C. Janson, et al; “European Community<br />
Respiratory Health Survey: What are the<br />
main results so far?”<br />
LWFR-EXP15-000807-<br />
LWFR-EXP15-000835<br />
LWFR-EXP15-000836-<br />
LWFR-EXP15-000838<br />
LWFR-EXP15-000839-<br />
LWFR-EXP15-000844<br />
LWFR-EXP15-000845-<br />
LWFR-EXP15-000858
242. Jerzy Kaminski, et al; “Determination of<br />
Formaldehyde in Fresh and Retail Milk<br />
by Liquid Colmn Chromatography”<br />
243. Teruhisa Kazui, MD, et al; “Role of<br />
Biologic Glue Repair of Proximal Aortic<br />
Dissection in the Development of Early<br />
and Midterm Redissection of the Aortic<br />
Root”<br />
244. Edward Kerfoot, PhD., et al;<br />
“Formaldehyde and Para<strong>formaldehyde</strong><br />
Study in Funeral Homes”<br />
245. Matthias Kirsch, MD., et al; “Aortic<br />
Alterations After Use of Gelatin-<br />
Resorci<strong>no</strong>l-Formalin Glue”<br />
246 Jame Koenig, PhD.; “Indoor and outdoor<br />
pollutants and the upper respiratory<br />
tract”<br />
247 Henrik Kolstad “Do Indoor Molds in<br />
Non-Industrial Environments Threaten<br />
Workers’ Health? A Review of the<br />
Epidemiologic Evidence”<br />
248 Koltai PJ “Effects of air pollution on the<br />
upper respiratory tract of children”<br />
21<br />
LWFR-EXP15-000859-<br />
LWFR-EXP15-000860<br />
LWFR-EXP15-000861-<br />
LWFR-EXP15-000866<br />
LWFR-EXP15-000867-<br />
LWFR-EXP15-000869<br />
LWFR-EXP15-000870-<br />
LWFR-EXP15-000873<br />
LWFR-EXP15-000874-<br />
LWFR-EXP15-000876<br />
LWFR-EXP15-000877-<br />
LWFR-EXP15-000891<br />
LWFR-EXP15-000892-<br />
LWFR-EXP15-000895<br />
249 Lab Rpt Badge 8-06-09 LWFR-EXP15-000896<br />
250 Lab Rpt Tube 8-06-09 LWFR-EXP15-000897<br />
251 Lee Ch, Maibach HI; “Study of<br />
cumulative irritant contact dermatitis in<br />
man utilizing open application on sub<br />
clinically irritated skin”<br />
LWFR-EXP15-000898-<br />
LWFR-EXP15-000903<br />
252 PR Morey PhD “Microbiological<br />
Contamination in Buildings”<br />
LWFR-EXP15-000904-<br />
LWFR-EXP15-000910<br />
253 Suzanne Gravesen “Microfungal<br />
Contamination of Damp Buildings”<br />
LWFR-EXP15-000911-<br />
LWFR-EXP15-000914<br />
254 Mold Culture Lab Rpt 8-29-09 LWFR-EXP15-000915-<br />
LWFR-EXP15-000918<br />
255 Michael C.R Alvanja “Mortality Study<br />
of Workers in Grain Industry”<br />
LWFR-EXP15-000919-<br />
LWFR-EXP15-000924<br />
256 MSDS Sheet Formaldehyde LWFR-EXP15-000925-<br />
LWFR-EXP15-000936<br />
257 Mycotoxins - Ruth A Etzel MD LWFR-EXP15-000937-<br />
LWFR-EXP15-000939<br />
258 Mycotoxins & Public Health - Malloy LWFR-EXP15-000940-<br />
CD Marr JS<br />
LWFR-EXP15-000949<br />
259 Tapani Tuomi “Mycotoxins in Crude LWFR-EXP15-000950-
Bldg Materials from Water Damaged<br />
Bldgs”<br />
260 NIOSH Criteria for a Recommended<br />
Standard - Occupational Exposure<br />
261 Sheila West “Non Viral Risk Factors for<br />
Nasopharyngeal Carci<strong>no</strong>ma in The<br />
Philippines”<br />
262 Norback, D, et al; “Asthmatic symptoms<br />
and violatile organic compounds,<br />
<strong>formaldehyde</strong> and carbon dioxide in<br />
dwellings”<br />
263 Ogunleye, et al; “Usual and unusual<br />
features of si<strong>no</strong>nasal cancer in Nigerian<br />
Africans; a prospective study of 27<br />
patients”<br />
264 Formaldehyde 2016, NIOSH Manual of<br />
Analytical Methods, Fourth Edition<br />
265 Formaldehyde by Vis 3500, NIOSH<br />
Manual of Analytical Methods, Fourth<br />
Edition<br />
266 OSHA Formaldehyde Sampling<br />
Method, Method Development Team,<br />
Industrial Hygiene Chemistry Division<br />
267 OSHA Formaldehyde Sampling Method<br />
1007, Method Development Team,<br />
Industrial Hygiene Chemistry Division<br />
268 X Weng, CH Chon, H Jiang, D Li,<br />
“Rapid Detection of Formaldehyde<br />
Concentration in Food on a<br />
Polydimethylsiloxane (PDMS)<br />
Microfluidic Chip” Food Chemistry 114<br />
(2009) 1079-1082.<br />
269 Evaluation of Formaldehyde Levels in<br />
Occupied Federal Emergency<br />
Management Agency-Owned Temporary<br />
Housing Units, National Center for<br />
Environmental Health.<br />
270 Franklin Mirer, “Risky Business:<br />
Forming Your Opinion of Katrina, Part<br />
1” The Synergist, January 2009<br />
271 LJ Salas and HB Singh, “Measurements<br />
of Formaldehyde and Acetaldehyde in<br />
the Urban Ambient Air” Atmospheric<br />
Environment Vol. 20 No. 6. (1986) pp.<br />
LWFR-EXP15-000955<br />
LWFR-EXP15-000956-<br />
LWFR-EXP15-000958<br />
LWFR-EXP15-000959-<br />
LWFR-EXP15-000965<br />
LWFR-EXP15-000966-<br />
LWFR-EXP15-000974<br />
LWFR-EXP15-000975-<br />
LWFR-EXP15-000981<br />
LWFR-EXP11-001662-<br />
LWFR-EXP11-001668<br />
LWFR-EXP11-001669-<br />
LWFR-EXP11-001673<br />
LWFR-EXP11-001691-<br />
LWFR-EXP11-001726<br />
LWFR-EXP11-001727-<br />
LWFR-EXP11-001758<br />
LWFR-EXP11-001962-<br />
LWFR-EXP11-001965.<br />
LWFR-EXP11-001926-<br />
LWFR-EXP11-001961<br />
LWFR-EXP11-001966-<br />
LWFR-EXP11-001969<br />
LWFR-EXP11-002128-<br />
LWFR-EXP11-002131<br />
22
1301-1304.<br />
272 OSHA Summary of Air and Noise<br />
Sampling Results Representing Actual<br />
or Potential Exposures for Response and<br />
Recovery Workers Involved in<br />
Hurricane Response and Recovery<br />
Activities<br />
273 DeVanny Industrial Consultants,<br />
Formaldehyde Sampling: Active and<br />
Passive Sampling Protocols March 2008<br />
274 Ohmichi, Kimihide “Formaldehyde<br />
Exposure in a Gross Anatomy<br />
Laboratory”<br />
275 Jonathan White “Oral Tolerance to<br />
Contact Allergens”<br />
276 Osguthorpe, David “Frontal Sinus<br />
Malignancies”<br />
23<br />
LWFR-EXP11-001759-<br />
LWFR-EXP11-001761<br />
LWFR-EXP11-001762-<br />
LWFR-EXP11-001890<br />
LWFR-EXP15-000982-<br />
LWFR-EXP15-000987<br />
LWFR-EXP15-000988-<br />
LWFR-EXP15-000996<br />
LWFR-EXP15-000997-<br />
LWFR-EXP15-001010<br />
277 OSHA Recognized Carci<strong>no</strong>gens LWFR-EXP15-001011-<br />
LWFR-EXP15-001012<br />
278 Michael Hodgson “Outbreak Recurrent LWFR-EXP15-001013-<br />
Chronic Hypersensitivity Pneumonitis LWFR-EXP15-001020<br />
office workers”<br />
279 B.A Owen, et al;” Formaldehyde in<br />
Drinking Water: Comparative Hazard<br />
Evaluation and an Approach to<br />
Regulation”<br />
280 Elizabeth Sherertz “Patch Testing<br />
Discordance Alert - False Negative<br />
Findings”<br />
281 Pattys Toxicology 5th Edition Volume 5<br />
- Aldehydes and Acetals<br />
282 Paustenbach, et al; “A recommended<br />
occupational exposure limit for<br />
<strong>formaldehyde</strong> based on irritation”<br />
283 Pediatrics- Toxic Effects of Indoor<br />
Molds March 2005<br />
284 Christina Scheel, et al; “Possible Sources<br />
of Sick Bldg Syndrome Tennesee<br />
Middle School”<br />
285 Paivi Rauni, et al; “Preliminary<br />
Description of Antigenic Components<br />
Characteristic”<br />
286 Michael Hodgson, et al; “Pulmonary<br />
Disease Associated with Cafeteria<br />
LWFR-EXP15-001021-<br />
LWFR-EXP15-001038<br />
LWFR-EXP15-00139-<br />
LWFR-EXP15-001040<br />
LWFR-EXP15-001041-<br />
LWFR-EXP15-001042<br />
LWFR-EXP15-001043-<br />
LWFR-EXP15-001090<br />
LWFR-EXP15-001091-<br />
LWFR-EXP15-001095<br />
LWFR-EXP15-000196-<br />
LWFR-EXP15-001100<br />
LWFR-EXP15-001101-<br />
LWFR-EXP15-001110<br />
LWFR-EXP15-001111-<br />
LWFR-EXP15-001116
Flooding”<br />
287 Tove Agner – “Formaldehye Allergy –<br />
A Follow Up Study”<br />
288 Arts – “Inhaled formaledhydeevaluation<br />
of sensory irritation in<br />
relation to carci<strong>no</strong>genicity”<br />
289 Arts – “Setting an indoor air exposure<br />
limit for <strong>formaldehyde</strong>_ Factors of<br />
concern”<br />
290 Ballarin, Cinzia – “Micronucleated Cells<br />
in Nasal Mucosa”<br />
291 Ballenger, MD, John J.– “Some Effects<br />
of Formaldehyde on the Upper<br />
Respiratory Tract”<br />
292 Barreto, Mauricio L. – “Risk Factors and<br />
Immu<strong>no</strong>logical Pathways for Asthma<br />
and Other Allergic Diseases in Children”<br />
293 Batra, Jyotsna – “Inductible Nitric Oxide<br />
Synthase”<br />
294 Berke, MD, Jerry H. – “Cytologic<br />
Examination of the Nasal Mucosa in<br />
Formaldehyde-exposed Workers”<br />
295 Bermudez – “Characterization of Cell<br />
Lines Derived from Formaldehyde-<br />
Induced Nasal Tumors in Rats”<br />
296 Blair – “Epidemiologic Evidence on the<br />
relationship between <strong>formaldehyde</strong><br />
exposure and cancer”<br />
297 Bolt – “Experimental Toxicology of<br />
Formaldehyde”<br />
298 Boysen – “Nasal Mucosa of Workers<br />
Exposed to HCHO”<br />
299 Bredt -“Endoge<strong>no</strong>us Nitric Oxide<br />
Synthesis”<br />
300 Brown, Sara J. – “Atopic Eczema and<br />
the Filaggrin Story”<br />
301 Bruynzeel – “Formaldehyde Contact<br />
Sensitivity and the use of Shampoo”<br />
302 Burgaz – “Micronuclei Frequencies in<br />
Exfoliated Nasal Mucosa Cells from<br />
Pathology and Anatomy Laboratory<br />
Workers”<br />
303 Casa<strong>no</strong>va – “Covalent Binding of<br />
Inhaled<br />
LWFR-EXP15-002179-<br />
LWFR-EXP15-002184<br />
LWFR-EXP15-002185-<br />
LWFR-EXP15-002201<br />
LWFR-EXP15-002202-<br />
LWFR-EXP15-002207<br />
LWFR-EXP15-002208-<br />
LWFR-EXP15-002214<br />
LWFR-EXP15-002215-<br />
LWFR-EXP15-002218<br />
LWFR-EXP15-002219-<br />
LWFR-EXP15-002228<br />
LWFR-EXP15-002229-<br />
LWFR-EXP15-002237<br />
LWFR-EXP15-002238-<br />
LWFR-EXP15-002242<br />
LWFR-EXP15-002243-<br />
LWFR-EXP15-002250<br />
LWFR-EXP15-002251-<br />
LWFR-EXP-002266<br />
LWFR-EXP15-000267-<br />
LWFR-EXP15-002272<br />
LWFR-EXP15-002273<br />
LWFR-EXP15-002279<br />
LWFR-EXP15-000280–<br />
LWFR-EXP15-002302<br />
LWFR-EXP15-002303-<br />
LWFR-EXP15-002313<br />
LWFR-EXP15-002314-<br />
LWFR-EXP15-002316<br />
LWFR-EXP15-002317-<br />
LWFR-EXP15-002321<br />
LWFR-EXP15-002322-<br />
LWFR-EXP15-002343<br />
24
Formaldehyde to DNA in the<br />
Respiratory<br />
Tract of Rhesus Monkeys”<br />
304 Casa<strong>no</strong>va – “DNA-Protein Cross-Links<br />
and Cell Replication at Specific Sites in<br />
the Nose of F344 Rats”<br />
305 Casarett & Doull's – Toxicology – “The<br />
Basic Science of Poisons” – Sixth<br />
Edition<br />
306 Casset – “Le Formaldehyde inhale et la<br />
response bronchique”<br />
25<br />
LWFR-EXP15-002344-<br />
LWFR-EXP15-002356<br />
LWFR-EXP15-002357-<br />
LWFR-EXP15-002358<br />
LWFR-EXP15-002359-<br />
LWFR-EXP15-002369<br />
307 Chan – “Atopic Dermatitis in 2008” LWFR-EXP15-002370-<br />
308 Chen, JJ– “Detoxification of Reactive<br />
Aldehydes in Mitochondria”<br />
309 Co<strong>no</strong>lly, Rory B. – “Human Respiratory<br />
Tract Cancer Risks of Inhaled<br />
Formaldehyde”<br />
310 Co<strong>no</strong>lly, Rory B. – “Simulation<br />
Modeling of the Tissue Disposition of<br />
Formaldehyde”<br />
311 Costa, Solange – “Ge<strong>no</strong>toxic Damage in<br />
Pathology Anatomy Laboratory Workers<br />
Exposed to Formaldehyde”<br />
312 Cronin – “Formaldehyde is a Significant<br />
Allergen in Women with Hand Eczema”<br />
313 Dales, MD, Robert– “Quality of indoor<br />
residential air and health”<br />
314 Davydov, Vadim V. – “Age-Related<br />
Changes in Activity of Enzymes<br />
Catalyzing Oxidation-Reduction”<br />
315 Davydov, Vadim V. – “Possible Role of<br />
Alteration of Aldehyde's Scavenger<br />
Enzymes During Aging”<br />
316 de Groot – “Patch Test Reactivity to<br />
DMDM Hydantoin”<br />
317 Delfi<strong>no</strong>, Ralph J.– “Asthma Symptoms<br />
in Hispanic Children and Daily Ambient<br />
Exposures to Toxic and Criteria Air<br />
Pollutants”<br />
318 Delfi<strong>no</strong>, Ralph J. – “Epidemiologic<br />
Evidence for Asthma and Exposure to<br />
Air Toxics: Linkages between<br />
Occupational, Indoor and Community<br />
LWFR-EXP15-002418<br />
LWFR-EXP15-002419-<br />
LWFR-EXP15-002427<br />
LWFR-EXP15-002428-<br />
LWFR-EXP15-002445<br />
LWFR-EXP15-002446-<br />
LWFR-EXP15-002453<br />
LWFR-EXP15-002454-<br />
LWFR-EXP15-002463<br />
LWFR-EXP15-002464-<br />
LWFR-EXP15-002470<br />
LWFR-EXP15-002471-<br />
LWFR-EXP15-002476<br />
LWFR-EXP15-002477-<br />
LWFR-EXP15-002480<br />
LWFR-EXP15-002481-<br />
LWFR-EXP15-002487<br />
LWFR-EXP15-002488–<br />
LWFR-EXP15-002493<br />
LWFR-EXP15-002494-<br />
LWFR-EXP15-002503<br />
LWFR-EXP15-002504-<br />
LWFR-EXP15-002520
Air Pollution Research”<br />
319 d'Errico – “A Case-control Study on<br />
Occupational Risk Factors for Si<strong>no</strong>-<br />
Nasal Cancer”<br />
320 Eberlein-Konig – “Influence of Airborne<br />
Nitrogen Dioxide or Formaldehyde on<br />
Parameters of Skin Function”<br />
321 Edling, C. – “Formaldehyde and the<br />
Nasal Mucosa”<br />
322 Edling, C. – “Occupational exposure to<br />
Formaldehyde and Histopathological<br />
Changes in the Nasal Mucosa”<br />
323 Edling, C. – “Occupational Exposure to<br />
Formaldehyde”<br />
324 Erdei, Esther – “Indoor Air Pollutants<br />
and Immune Biomarkers among<br />
Hungarian Asthmatic Children”<br />
325 Fischer, A. – “Clinical Standardization<br />
of the TRUE Test Formaldehyde Patch”<br />
326 Fischer , A.– “Mediators of Asthma –<br />
Nitric Oxide”<br />
327 Fleming – “Patch Testing in Discoid<br />
Eczema”<br />
328 Flyvholm – “Allergic Contact Dermatitis<br />
From Formaldehyde”<br />
329 Franklin, Peter – “Raised Exhales Nitric<br />
Oxide in Healthy Children is Associated<br />
With Domestic Formaldehyde Levels”<br />
330 Garrett, M.H. – “Errata for Increased<br />
Risk of Allergy in Children due to<br />
Formaldehyde Exposure in Homes”<br />
331 Garrett, M.H. – “Increased risk of<br />
allergy in children due to <strong>formaldehyde</strong><br />
exposure in homes”<br />
332 Giwercman, Charlotte – “Classification<br />
of Atopic Hand Eczema and the<br />
Filaggrin Mutations”<br />
333 Gu, YH – “Long-term Exposure to<br />
Gaseous Formaldehyde Promotes<br />
allergen –specific<br />
IgE-mediated Immune Responses in a<br />
Murine Model”<br />
334 Hansen, Johnnie – “Formaldehyde and<br />
cancer Morbidity among male<br />
LWFR-EXP15-002521-<br />
LWFR-EXP15-002541<br />
LWFR-EXP15-002542-<br />
LWFR-EXP15-002544<br />
LWFR-EXP15-002545-<br />
LWFR-EXP15-002546<br />
LWFR-EXP15-002547-<br />
LWFR-EXP15-002554<br />
LWFR-EXP15-002555-<br />
LWFR-EXP15-002566<br />
LWFR-EXP15-002567-<br />
LWFR-EXP15-002578<br />
LWFR-EXP15-002579-<br />
LWFR-EXP15-002587<br />
LWFR-EXP15-002588-<br />
LWFR-EXP15-002598<br />
LWFR-EXP15-002599-<br />
LWFR-EXP15-002603<br />
LWFR-EXP15-002604-<br />
LWFR-EXP15-002615<br />
LWFR-EXP15-002616-<br />
LWFR-EXP15-002618<br />
LWFR-EXP15-002619-<br />
LWFR-EXP15-002620<br />
LWFR-EXP15-002621-<br />
LWFR-EXP15-002628<br />
LWFR-EXP15-002629-<br />
LWFR-EXP15-002632<br />
LWFR-EXP15-002633-<br />
LWFR-EXP15-002640<br />
LWFR-EXP15-00264-<br />
LWFR-EXP15-002647<br />
26
employees in Denmark”<br />
335 Hauptmann, Michael – “Mortality from<br />
Lymphohemtopoietic Malignancies<br />
Among Workers in Formaldehyde<br />
Industries”<br />
336 Hauptmann, Michale –“ Mortality from<br />
Solid Cancers among Workers in<br />
Formaldehyde Industries”<br />
337 Hayes, Richard B.- “Cancer of the nasal<br />
cavity and paranasal sinuses, and<br />
<strong>formaldehyde</strong> exposure”<br />
338 Hayes, Richard B.– “Mortality of <strong>US</strong><br />
Embalmers and Funeral Directors”<br />
339 Hayes, Richard B. – “Wood Related<br />
Occupations, Wood Dust Exposure and<br />
Si<strong>no</strong>nasal Cancer”<br />
340 Held, Elisabeth – “Contact Allergy to<br />
Cosmetics: Testing with Patients’ Own<br />
Products”<br />
341 Henderson, Edward M. – “SNOR and<br />
Wheeze: The Asthma Enzyme”<br />
342 Hester, Susan D. – “Formaldehyde<br />
Inducced Gene Expression in F344 Rat<br />
Nasal Respiratory Epithelium”<br />
343 Holmstrom, M. – “Histological Changes<br />
in the Nasal Mucosa in Persons<br />
Occupationally Exposed to<br />
Formaldehyde”<br />
344 Holmstrom, M. – “Histological Changes<br />
in the Nasal Mucosa in Rats after Long<br />
Term Exposure”<br />
345 Holmstrom, M. – “Respiratory<br />
Symptoms and Pathophysiological<br />
Effects of Occupational Exposure to<br />
Formaldehyde and Wood Dust”<br />
346 Hovding – “Contact Eczema Due to<br />
Formaldehyde in Resin Finished<br />
Textiles”<br />
347 Ionescu, Jean – “Experimental Chronic<br />
Obstructive Lung Disease.<br />
Bronchopulmonary Changes Induced<br />
in Rabbits by Prolonged Exposure to<br />
Formaldehyde”<br />
27<br />
LWFR-EXP15-002648-<br />
LWFR-EXP15-002656<br />
LWFR-EXP15-002657-<br />
LWFR-EXP15-002670<br />
LWFR-EXP15-002671-<br />
LWFR-EXP15-002676<br />
LWFR-EXP15-002677-<br />
LWFR-EXP15-002688<br />
LWFR-EXP15-002689-<br />
LWFR-EXP15-002694<br />
LWFR-EXP15-002695-<br />
LWFR-EXP15-002700<br />
LWFR-EXP15-002701-<br />
LWFR-EXP15-002704<br />
LWFR-EXP15-002705-<br />
LWFR-EXP15-002717<br />
LWFR-EXP15-002718-<br />
LWFR-EXP15-002730<br />
LWFR-EXP15-002731-<br />
LWFR-EXP15-002741<br />
LWFR-EXP15-002742-<br />
LWFR-EXP15-002747<br />
LWFR-EXP15-002748-<br />
LWFR-EXP15-002755<br />
LWFR-EXP15-002756-<br />
LWFR-EXP15-002771<br />
348 Jeffery, P.K. –“ Differences and LWFR-EXP15-002772-
Similarities between Chronic<br />
Obstructive Pulmonary Disease and<br />
Asthma”<br />
349 Kamata – “Results of a 28-Month<br />
Chronic Inhalation Toxicity Study of<br />
Formaldehyde in Male Fisher – 344<br />
Rats”<br />
350 Kerns, William D.- “Carci<strong>no</strong>genicity of<br />
Formaldehyde in Rata and Mice After<br />
Long-Term Inhalation Exposure”<br />
351 Kimbell, Julia – “Correlation of<br />
Regional Formaldehyde Flux Predictions<br />
with the Distribution of Formaldehydeinduced<br />
squamous metaplasia in F344<br />
Rat Nasal Passages”<br />
352 Kimbell, Julia-“ Nasal Dosimetry of<br />
Inhaled Gases and Particles”<br />
353 Krzyza<strong>no</strong>wski, Michal – “Chronic<br />
Respiratory Effects of Indoor<br />
Formaldehyde Exposure”<br />
354 Li<strong>no</strong>s – “Leukemia and Non-Hodgkin's<br />
Lymphoma Among Embalmers and<br />
Funeral Directors”<br />
355 Luce – “Si<strong>no</strong>nasal Cancer and<br />
Occupational<br />
Exposure to Formaldehyde and Other<br />
Substances”<br />
356 Maibach, Howard – “Formaldehyde -<br />
Effects on Animal and Human Skin”<br />
357 Maronpot, R.R. – “Toxicity of<br />
Formaldehyde Vapor in B6C3F1<br />
Mice”<br />
358 Matsunaga – “Ambient Formaldehyde<br />
Levels and Allergic Disorders Among<br />
Japanese Pregnant Women”<br />
359 Maurice, F. – “Anaphylactic Shock<br />
Caused by Formaldehyde”<br />
360 McGregor, D. – “Formaldehyde and<br />
Glutaraldehyde and Nasal Cytotoxicity”<br />
361 Mi – “Current asthma and respiratory<br />
symptoms among pupils in Shanghai,<br />
China”<br />
362 Mi – “Current asthma and respiratory<br />
symptoms among pupils in Shanghai,<br />
LWFR-EXP15-002785<br />
LWFR-EXP15-002786-<br />
LWFR-EXP15-002803<br />
LWFR-EXP15-002804-<br />
LWFR-EXP15-002814<br />
LWFR-EXP15-002815-<br />
LWFR-EXP15-002825<br />
LWFR-EXP15-002826-<br />
LWFR-EXP15-002830<br />
LWFR-EXP15-002831-<br />
LWFR-EXP15-002839<br />
LWFR-EXP15-002840-<br />
LWFR-EXP15-002841<br />
LWFR-EXP15-002842-<br />
LWFR-EXP15-002850<br />
LWFR-EXP15-002851-<br />
LWFR-EXP15-002855<br />
LWFR-EXP15-002856-<br />
LWFR-EXP15-002870<br />
LWFR-EXP15-002871-<br />
LWFR-EXP15-002877<br />
LWFR-EXP15-002878-<br />
LWFR-EXP15-002879<br />
LWFR-EXP15-002880-<br />
LWFR-EXP15-002896<br />
LWFR-EXP15-002897-<br />
LWFR-EXP15-002908<br />
LWFR-EXP15-002897-<br />
LWFR-EXP15-002908<br />
28
China”<br />
363 Monticello, Thomas M.-“ Cell<br />
Proliferation and Formaldehyde-Induced<br />
Respiratory Carci<strong>no</strong>genesis”<br />
364 Monticello, Thomas M. – “Effects of<br />
Formaldehyde Gas on the Respiratory<br />
Tract of Rhesus Monkeys”<br />
365 Nederost, Susan T. – “The Role of Patch<br />
Testing for Chemical and Protein<br />
Allergens in Atopic Dermatitis”<br />
366 Nielsen, G. Damgard – “Acute Airway<br />
Effects of Formaldehyde and Ozone in<br />
BALBc Mice”<br />
367 Olsen, J. H. – “Formaldehyde and the<br />
Risk of Squamous Cell Carci<strong>no</strong>ma of the<br />
Si<strong>no</strong>nasal Cavities”<br />
368 Olsen, J.H. –“ Formaldehyde induced<br />
symptoms in day care centers”<br />
369 Olsen, J.H. – “Occupational<br />
<strong>formaldehyde</strong> exposure and increased<br />
nasal cancer risk in man”<br />
370 Olsen, J. H. – “Occupational Risks of<br />
Si<strong>no</strong>nasal Cancer in Denmark”<br />
371 Ott, M. Gerald – “Lymphatic and<br />
Hematopoietic Tissue Cancer in<br />
Chemical Manufacturing Environment”<br />
372 Parmigiani - Ethotoxicology-“An<br />
Evolutionary Approach to the Study of<br />
Environmental Endocrine-Disrupting<br />
Chemicals”<br />
373 Pati, S.-“ Indoor Environmental Risk<br />
Factors for Asthma and Respiratory Ill<br />
Health in Preschool Children”<br />
374 Patty’s Toxicology – 5 th Edition –<br />
Volume 5<br />
“Aldehydes and Acetals”<br />
375 Pazdrak, Konrad- “Changes in nasal<br />
lavage fluid due to HCHO inhalation”<br />
376 Pedersen – “Occupational Hand Eczema<br />
from Formaldehyde in Price Labels”<br />
377 Pinkerton, L.E. – “Mortality among a<br />
cohort of garment workers exposed to<br />
Formaldehyde”<br />
29<br />
LWFR-EXP15-002915-<br />
LWFR-EXP15-002922<br />
LWFR-EXP15-002923-<br />
LWFR-EXP15-002935<br />
LWFR-EXP15-002936-<br />
LWFR-EXP15-002941<br />
LWFR-EXP15-002942-<br />
LWFR-EXP15-002953<br />
LWFR-EXP15-002954-<br />
LWFR-EXP15-002960<br />
LWFR-EXP15-002961-<br />
LWFR-EXP15-002966<br />
LWFR-EXP15-002967-<br />
LWFR-EXP15-002972<br />
LWFR-EXP15-002973-<br />
LWFR-EXP15-002979<br />
LWFR-EXP15-002980-<br />
LWFR-EXP15-002992<br />
LWFR-EXP15-002993-<br />
LWFR-EXP15-003000<br />
LWFR-EXP15-003001-<br />
LWFR-EXP15-003002<br />
LWFR-EXP15-003003-<br />
LWFR-EXP15-003016<br />
LWFR-EXP15-003017-<br />
LWFR-EXP15-003021<br />
LWFR-EXP15-003022-<br />
LWFR-EXP15-003024<br />
LWFR-EXP15-003025-<br />
LWFR-EXP15-003032<br />
378 Recio, Leslie – “Oncogene and Tumor LWFR-EXP15-003033-
Supressor Gene Alterations in Nasal LWFR-EXP15-003038<br />
Tumors”<br />
379 Roitt - Immu<strong>no</strong>logy Seventh Edition LWFR-EXP15-003039-<br />
LWFR-EXP15-003040<br />
380 Rostenberg, A. – “A Study of<br />
Eczematous Sensitivity to<br />
Formaldehyde”<br />
LWFR-EXP15-003041-<br />
LWFR-EXP15-003045<br />
381 Rumchev, K.B. –“ Domestic exposure to<br />
<strong>formaldehyde</strong> significantly increases the<br />
risk of asthma in young children”<br />
382 Rusch, George M. – “A 26 Week<br />
Inhalation Toxicity Study With<br />
Formaldehyde in the Monkey, Rat and<br />
Hamster”<br />
30<br />
LWFR-EXP15-003046-<br />
LWFR-EXP15-003051<br />
LWFR-EXP15-003052-<br />
LWFR-EXP15-003066<br />
383 Shaham - DNA-Protein Cross-Links LWFR-EXP15-003067-<br />
LWFR-EXP15-003076<br />
384 Sittig, Marshall – “Handbook of Toxic<br />
and Hazardous Chemicals and<br />
Carci<strong>no</strong>gens”<br />
LWFR-EXP15-003077-<br />
LWFR-EXP15-003082<br />
385 Smedje – “Asthma among secondary<br />
schoolchildren<br />
in relation to the school environment”<br />
386 Smedje – “Incidence of Asthma<br />
Diag<strong>no</strong>sis and Self-Reported Allergy”<br />
387 Stellman, Steven D. – “Cancer Mortality<br />
and Wood Dust Exposure Among<br />
Participants In The American Cancer<br />
Society Cancer Prevention Study-II”<br />
388 Stroup, Nancy E. – “Brain Cancer and<br />
Other Causes of Death in Anatomists”<br />
389 Swenberg, James A. –“ Induction of<br />
Squamous Cell Carci<strong>no</strong>mas of the Rat<br />
Nasal Cavity”<br />
390 Takahashi, Sachiko– “Prospective Study<br />
of Clinical Symptoms and Skin Test<br />
Reactions in Medical Students”<br />
391 Tavernier, Gael - IPEADAM study –<br />
“indoor endotoxin exposure”<br />
392 Thompson – “Mechanistic and Dose<br />
Considerations for Support Adverse<br />
Pulmonary Physiology”<br />
393 Thompson – “Mechanistic<br />
Considerations for HCHO induced<br />
bronchoconstriction”<br />
LWFR-EXP15-003083-<br />
LWFR-EXP15-003092<br />
LWFR-EXP15-003093-<br />
LWFR-EXP15-003100<br />
LWFR-EXP15-003102-<br />
LWFR-EXP15-003110<br />
LWFR-EXP15-003111-<br />
LWFR-EXP15-003118<br />
LWFR-EXP15-003119-<br />
LWFR-EXP15-003123<br />
LWFR-EXP15-003124-<br />
LWFR-EXP15-003131<br />
LWFR-EXP15-003132-<br />
LWFR-EXP15-003138<br />
LWFR-EXP15-003139-<br />
LWFR-EXP15-003144<br />
LWFR-EXP15-003145-<br />
LWFR-EXP15-003150
394 Til – “Evaluation of Oral Toxicity of<br />
Acetaldehyde and Formaldehyde”<br />
395 Til – “Two-Year Drinking-Water Study<br />
of Formaldehyde in Rats”<br />
396 <strong>US</strong> DHH – “Toxicology Profile for<br />
Formaldehyde”<br />
397 <strong>US</strong> EPA – “Formaldehyde Hazard<br />
Summary”<br />
398 Vaughan – “Formaldehyde and Cancers<br />
of the Pharynx, Sinus and Nasal Cavity<br />
1”<br />
399 Vaughan – “Formaldehyde and Cancers<br />
of the Pharynx, Sinus and Nasal Cavity<br />
2”<br />
400 Vaughan – “Occupational Exposure to<br />
Formaldehyde and Wood Dust and<br />
Nasopharyngeal Carci<strong>no</strong>ma copy”<br />
401 von Bub<strong>no</strong>ff – “Dendritic Cells and<br />
Atopic Eczema-Dermatitis Syndrome”<br />
Walrath – “Motality Patterns Among<br />
Embalmers”<br />
Wantke – “Exposure to gaseous HCHO<br />
induces<br />
IgE-Mediated sensitization to HCHO”<br />
West – “Non-Viral Risk Factors for<br />
Nasopharyngeal Carci<strong>no</strong>ma in the<br />
Phillippines- Results from a Case<br />
Control Study copy”<br />
Weston – “Type IV Reactions in the<br />
Skin”<br />
Wilmer – “Subacute 4-week Inhalation<br />
Toxicity Study”<br />
Wilmer – “Subchronic 13-week<br />
Inhalation Toxicity Study of<br />
Formaldehyde in Male Rats”<br />
World Health Organization -<br />
Environmental Health Criteria –<br />
Formaldehyde<br />
World Health Organization - IARC<br />
Mo<strong>no</strong>graphs on the Evaluation of<br />
Carci<strong>no</strong>genic Risks to Humans<br />
Woutersen – “Subchronic 13-Week<br />
Inhalation Toxicity Study of<br />
LWFR-EXP15-003151-<br />
LWFR-EXP15-003158<br />
LWFR-EXP15-003159-<br />
LWFR-EXP15-003170<br />
LWFR-EXP15-003171-<br />
LWFR-EXP15-003638<br />
LWFR-EXP15-003639-<br />
LWFR-EXP15-003643<br />
LWFR-EXP15-003644-<br />
LWFR-EXP15-003650<br />
LWFR-EXP15-003651-<br />
LWFR-EXP15-003655<br />
LWFR-EXP15-003656-<br />
LWFR-EXP15-003664<br />
LWFR-EXP15-003665-<br />
LWFR-EXP15-003670<br />
LWFR-EXP15-003671–<br />
LWFR-EXP15-003676<br />
LWFR-EXP15-003677-<br />
LWFR-EXP15-003682<br />
LWFR-EXP15-003683-<br />
LWFR-EXP15-003688<br />
LWFR-EXP15-003689-<br />
LWFR-EXP15-003693<br />
LWFR-EXP15-003694-<br />
LWFR-EXP15-003697<br />
LWFR-EXP15-003698-<br />
LWFR-EXP15-003705<br />
LWFR-EXP15-003706-<br />
LWFR-EXP15-003876<br />
LWFR-EXP15-003877-<br />
LWFR-EXP15-003877<br />
LWFR-EXP15-003878-<br />
LWFR-EXP15-003886<br />
31
Formaldehyde in Rats”<br />
Wuthrich – “Atopic Eczema - Genetics<br />
or Environment”<br />
Zhao – “Asthmatic Symptoms among<br />
Pupils in Relation to Winter Indoor and<br />
Outdoor Air Pollution”<br />
Zwart – “Cytotoxic and Adaptive Effects<br />
in Rat Nasal Epithelium”<br />
02-21-1989 - Formaldehyde Standard<br />
Clarification<br />
08-07-1987 - Cancer warning labels for<br />
<strong>formaldehyde</strong> and products containing<br />
<strong>formaldehyde</strong><br />
32<br />
LWFR-EXP15-003887-<br />
LWFR-EXP15-003893<br />
LWFR-EXP15-003894-<br />
LWFR-EXP15-003902<br />
LWFR-EXP15-003903-<br />
LWFR-EXP15-003916<br />
LWFR-EXP15-003917-<br />
LWFR-EXP15-003918<br />
LWFR-EXP15-003919-<br />
LWFR-EXP15-003920<br />
29 CFR 1910.1000-END LWFR-EXP15-003921-<br />
LWFR-EXP15-003940<br />
Affidavit of Patricia Williams in the LWFR-EXP15-003941-<br />
Trial of Alana Alexander and<br />
LWFR-EXP15-003942<br />
Christopher Cooper<br />
Casual Evidence of Carci<strong>no</strong>genicity<br />
from<br />
Ge<strong>no</strong>toxicity and Cytoxicity<br />
Documentation for Immediately<br />
Dangerous<br />
to Life or Health Concentrations<br />
(IDLHs) – 50000<br />
Formaldehyde - 1910.1048<br />
Formaldehyde - 5246168-312<br />
Formaldehyde presentation<br />
demonstrative evidence<br />
Hazard Communication – 1910<br />
IARC Mo<strong>no</strong>graphs Programme on the<br />
Evaluation of Carci<strong>no</strong>genic Risks to<br />
Humans pgs 9, 11, 15-17, 23, 33<br />
Intro to 29 CFR Part 1910, Occupational<br />
Exposure to Formaldehyde<br />
List of all the times analyzed strength of<br />
association in epidemiologic studies in<br />
toxic tort litigation<br />
Medical Surveillance - Formaldehyde -<br />
1910_1048 App C<br />
NIOSH 77-126a-f<br />
LWFR-EXP15-003943-<br />
LWFR-EXP15-003943<br />
LWFR-EXP15-003944-<br />
LWFR-EXP15-003945<br />
LWFR-EXP15-003946-<br />
LWFR-EXP15-003967<br />
LWFR-EXP15-003968-<br />
LWFR-EXP15-003969<br />
LWFR-EXP15-003970-<br />
LWFR-EXP15-004019<br />
LWFR-EXP15-004020-<br />
LWFR-EXP15-004042<br />
LWFR-EXP15-004043-<br />
LWFR-EXP15-004049<br />
LWFR-EXP15-004050-<br />
LWFR-EXP15-004051<br />
LWFR-EXP15-004052-<br />
LWFR-EXP15-004053<br />
LWFR-EXP15-004054-<br />
LWFR-EXP15-004057<br />
LWFR-EXP15-004058-
NIOSH Pocket Guide to Chemical<br />
Hazards<br />
NIOSH-Respirator Use Policy for<br />
Protection<br />
Against Carci<strong>no</strong>gens<br />
Null Hypothesis Sir Ronald Fisher0001<br />
OSHA Recognized Carci<strong>no</strong>gens<br />
OSHA Safety and Health Standards 29<br />
CFR 1910<br />
Reference Guide on Epidemiology pg<br />
333 and 358<br />
Reference Guide on Toxicology pgs<br />
336-337, 378, 407-408, 415<br />
Modern Epidemiology – 2 nd Edition –<br />
Causal Interference in Epidemiology<br />
Section 6-VI_Health Effects Discussion<br />
and Determination of Final PEL<br />
Ward, Kathleen – “A Comparison of<br />
Expression of Surface – bound<br />
Immu<strong>no</strong>globulin E on Antigen –<br />
presenting cells in cutaneous tissue<br />
between patients with allergic, irritant<br />
and atopic dermatitis”<br />
Zweiman – “The Late Phase Reaction -<br />
Role of IgE, its Receptor and Cytokines”<br />
Beane Mortality From<br />
Lyphohematopoietic Malingancies<br />
Zhang - Formaldehyde exposure and<br />
leukemia<br />
Quievryn - Loss of DNA - Protein<br />
Crosslinks from Formaldehyde<br />
Hauptmann 2009 - Mortality from<br />
Lymphohematopoietic Malignancies<br />
Coglia<strong>no</strong> - Advice of Formaldehyde and<br />
Glycol Ethers<br />
Coglia<strong>no</strong> - Summary of IARC<br />
Mo<strong>no</strong>graphs on Formaldehyde<br />
Barker - DNA Protein Crosslinks<br />
Merk - Significance of Formaldehyde<br />
Induced DNA Protein Cross links<br />
33<br />
LWFR-EXP15-004234<br />
LWFR-EXP15-004235-<br />
LWFR-EXP15-004244<br />
LWFR-EXP15-004245-<br />
LWFR-EXP15-004246<br />
LWFR-EXP15-004247-<br />
LWFR-EXP15-004249<br />
LWFR-EXP15-004250-<br />
LWFR-EXP15-004251<br />
LWFR-EXP15-004252-<br />
LWFR-EXP15–004259<br />
LWFR-EXP15-004260-<br />
LWFR-EXP15-004261<br />
LWDR-EXP15-004262-<br />
LWDR-EXP15-004267<br />
LWFR-EXP15-004268-<br />
LWFR-EXP15-004269<br />
LWFR-EXP15-004270-<br />
LWFR-EXP15-004829<br />
LWFR-EXP15-004830-<br />
LWFR-EXP15-004837<br />
LWFR-EXP15-004838-<br />
LWFR-EXP15-004843<br />
LWFR-EXP15-004846-<br />
LWFR-EXP15-004865<br />
LWFR-EXP15-004866-<br />
LWFR-EXP15-004884<br />
LWFR-EXP15-004885-<br />
LWFR-EXP15-004892<br />
LWFR-EXP15-004893-<br />
LWFR-EXP15-004905<br />
LWFR-EXP15-004906-<br />
LWFR-EXP15-004906<br />
LWFR-EXP15-004907-<br />
LWFR-EXP15-004911<br />
LWFR-EXP15-004912-<br />
LWFR-EXP15-004937<br />
LWFR-EXP15-004938-<br />
LWFR-EXP15-004947
Wright Trial Power point demonstrative<br />
evidence Chart on Formaldehyde<br />
concentrations and eczema<br />
Chart on Formaldehyde concentrations<br />
and cancers<br />
Chart on Formaldehyde concentrations<br />
and Ge<strong>no</strong>toxicity and Cytotoxicity<br />
Report of Patricia M. Williams PhD,<br />
DABT on Lyndon Wright<br />
Charts on error rate/false positives/false<br />
negatives of TRUE Test<br />
Chart on Reproducibility of TRUE Test<br />
results<br />
Diagram of chemical reactions in TRUE<br />
Test<br />
Chart on OSHA and gaseous<br />
Formaldehyde and eczema and cancer<br />
Chart on Scientific Literature and<br />
Cancers and Formaldehyde<br />
Chart on Sensitive Populations<br />
Chart on ATSDR Minimal Risk Levels<br />
Chart on Scientific Methodology<br />
Chart on DNA damage and<br />
consequences to the cell<br />
Chart on epidemiologic flaws of Cohort<br />
studies vs Case studies<br />
Reference Manual Scientific Evidence,<br />
2 nd Edition (2000)<br />
Gollhausen, et al., Reproducibility of<br />
Patch Test results- Comparison of TRUE<br />
Test, Journal of American Academy of<br />
Dermatology, 1989<br />
Dales, et al., Respiratory Health Effects<br />
of Home Dampness and Molds among<br />
Canadian Children, American Journal of<br />
Epidemiology, 1991.<br />
Riddle, HF, Prevalence of Respiratory<br />
Respiratory Symptoms and Sensitization<br />
by Mould Antigens among a group of<br />
Maltworkers, Brit. Journal of Ind. Med.<br />
(1974)<br />
Revankar, S, Clinical Implications of<br />
Mycotoxins and Stachybotrys,<br />
Southwestern Internal Medicine Conf.<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
LWFR-EXP 15-001117-<br />
LWFR-EXP15-001763<br />
LWFR-EXP 15-001764-<br />
LWFR-EXP15-001768<br />
LWFR-EXP 15-001769-<br />
LWFR-EXP15-001776<br />
LWFR-EXP 15-001777-<br />
LWFR-EXP15-001782<br />
LWFR-EXP 15-001783-<br />
LWFR-EXP15-001796<br />
34
(2003)<br />
Hendry, et al., Review of Mycotoxins in<br />
Indoor Air, Journal of Toxicology and<br />
Env. Science (1993)<br />
Zachariae, et al., ROAT- Mophology of<br />
Roat on Arm, Neck and Face in<br />
<strong>formaldehyde</strong> and diazolidinyl urea<br />
sensitive individuals, Contact Dermatitis<br />
(2006)<br />
Simon, Textbook of Forensic<br />
Psychiatry, American Psychiatric<br />
Publishing, Inc., Washington DC, 2004<br />
Leung, Donald YM, Role of IGE in<br />
Atopic Dermatitis, Current Opinions in<br />
immu<strong>no</strong>logy (1993)<br />
Rumchev, et al, Association of domestic<br />
exposure to volatile organic compounds<br />
with asthma in young children<br />
Rumchev, et al, Domestic Exposure to<br />
Formaldehyde significantly increases<br />
the risk of asthma in young children, Eur<br />
Respir J (2002)<br />
Ruoppi, et al., Nasal symptoms among<br />
residents in moldy housing, Scand. J.<br />
Work Environ Health (2003)<br />
Schacter, et al., A Study of Respiratory<br />
Effects from Exposure to 2.0 ppm<br />
Formaldehyde in Occupationally<br />
Exposed Workers, Environmental<br />
Research (1987)<br />
Scheynius, et al., Absence of specific IgE<br />
antibodies in allergic contact sensitivity<br />
to <strong>formaldehyde</strong>, Allergy (1993)<br />
Schnuch, et al., Quantitative patch and<br />
repeated open application testing in<br />
hydroxyisohexyl 3-cyclohexene<br />
carbohaldehyde sensitive-patients,<br />
Contact Dermatitis (2009)<br />
Sciandra, et al., Pleomorphic ade<strong>no</strong>ma<br />
of the lateral nasal wall: case report,<br />
Acta Otorhi<strong>no</strong>laryngologica (2008)<br />
Shin, et al., Chronic Rhi<strong>no</strong>sinustis: An<br />
enhanced immune response to<br />
ubiquitous airborne fungi, Journal of<br />
LWFR-EXP 15-001797-<br />
LWFR-EXP15-001812<br />
LWFR-EXP 15-001813-<br />
LWFR-EXP15-001817<br />
LWFR-GEN-000003 –<br />
LWFR-GEN-000014<br />
LWFR-EXP 15-001818-<br />
LWFR-EXP15-001824<br />
LWFR-EXP 15-001825-<br />
LWFR-EXP15-001832<br />
LWFR-EXP 15-001833-<br />
LWFR-EXP15-001838<br />
LWFR-EXP 15-001839-<br />
LWFR-EXP15-001846<br />
LWFR-EXP 15-001847-<br />
LWFR-EXP15-001867<br />
LWFR-EXP 15-001868-<br />
LWFR-EXP15-00<strong>1873</strong><br />
LWFR-EXP 15-001874-<br />
LWFR-EXP15-001885<br />
LWFR-EXP 15-001886-<br />
LWFR-EXP15-001889<br />
LWFR-EXP 15-001890-<br />
LWFR-EXP15-001897<br />
35
allergy and clinical immu<strong>no</strong>logy (2004)<br />
Shio<strong>no</strong>, Mutomi, Surgery for acute<br />
aortic dissection using gelatinresourcin-formalin<br />
glue, J. Artif. Organs<br />
(2008)<br />
Simoni, et al., Mould/dampness<br />
exposure at home is associated with<br />
respiratory disorders in Italian Children<br />
and adolescents, (2005)<br />
Yuotunde, et al., Si<strong>no</strong>nasal<br />
Malignancies: A 10-Year Review in a<br />
Tertiary Health Institution, Journal of<br />
the National Medical Association (2007)<br />
Skorge, et al., Indoor exposures and<br />
respiratory symptoms in a Norwegian<br />
community sample, Thorax (2004)<br />
Kwon, et al., Sooty Mold of Persimmon-<br />
Caused by Cladosporium cladospioides,<br />
Plant Pathol. J. (2003)<br />
Sosrose<strong>no</strong>, Wihaskoro, A review of the<br />
mechanisms of oral tolerance and<br />
immu<strong>no</strong>therapy, Journal of the Society<br />
of Medicine (1995)<br />
Speit, et al., The Human Lung Cell Line<br />
A549 Does Not Develop Adaptive<br />
Protection Against the DNA-Damaging<br />
Action of Formaldehyde, Env. And<br />
Molecular Mutogenes (2009)<br />
Takahashi, et al., Prospective study of<br />
clinical symptoms and skin test reactions<br />
in medical students exposed to<br />
<strong>formaldehyde</strong> gas, Japanese<br />
Dermatological Association (2007)<br />
Takigawa, et al., Reduction of Indoor<br />
Formaldehyde Concentrations and<br />
Subjective Symptoms in a Gross<br />
Anatomy Laboratory, Bull. Environ.<br />
Contam. Toxicol (2005)<br />
Fisher, Ronald A., The Design of<br />
Experiments, Harper Publishing<br />
Toomarian, et al., Histopathological<br />
evaluation of pulpotomy, Lasers Med.<br />
Sci. (2008)<br />
36<br />
LWFR-EXP15-001898-<br />
LWFR-EXP15-001902<br />
LWFR-EXP 15-001908-<br />
LWFR-EXP15-001916<br />
LWFR-EXP 15-001917-<br />
LWFR-EXP15-001920<br />
LWFR-EXP 15-001921-<br />
LWFR-EXP15-001928<br />
LWFR-EXP 15-001929-<br />
LWFR-EXP15-001931<br />
LWFR-EXP 15-001332-<br />
LWRF-EXP15-001936<br />
LWFR-EXP 15-001944-<br />
LWFR-EXP15-001951<br />
LWFR-EXP 15-001952-<br />
LWFR-EXP15-001959<br />
LWFR-EXP 15-001968-<br />
LWFR-EXP15-001971<br />
LWFR-EXP 15-001972-<br />
LWFR-EXP15-001973<br />
LWFR-EXP 15-001974-<br />
LWFR-EXP15-001981<br />
Tortorici, et al., Maxillary bone necrosis LWFR-EXP 15-001982-
following the use of <strong>formaldehyde</strong><br />
containing paste: management and case<br />
series, British Dental Journal (2007)<br />
Towers, et al., Maxillary sinusitis<br />
mimicking malignant disease, Oral.<br />
Surg. (1975)<br />
Jarvis, et al., Toxigenic Molds in Water<br />
Damaged Buildings, Journal of Nat.<br />
Prod. (1996)<br />
Sorenson, et al., Trichothecene<br />
Mycotoxins in Aerosolized- Conidia of<br />
Stachyboltrys Atra, Applied and<br />
Environ. Microbiology (1987)<br />
Fisher, et al., Fundamentals of<br />
Diag<strong>no</strong>stic Mycology, 1996<br />
Uba, et al., Prospective Study of<br />
Respiratory Effects of Formaldehyde<br />
Among Healthy and Asthmatic Medical<br />
Students, Am. Journal of Ind. Med.<br />
(1989)<br />
Ue<strong>no</strong>, Yoshio, The Toxicology of<br />
Mycotoxins, Critical Reviews in<br />
Toxicology<br />
Ue<strong>no</strong>, Yoshio, Trichothecenes Overview<br />
Address<br />
Van Hoogstraten, et al., Persistent<br />
Immune Tolerance to Nickel and<br />
Chromium by Oral Administration Prior<br />
to Cutaneous Sensitization, Journal of<br />
Investigative Dermatology (1992)<br />
Venn, et al., Effects of volatile organic<br />
compounds, damp, and and other<br />
environmental exposures in the home on<br />
wheezing illness in children, Thorax<br />
(2003)<br />
Vilarma and Maibach, Correlations of<br />
patch test reactivity and the repeated<br />
open application test<br />
(ROAT)/provocative use test (PUT),<br />
Food and Chemical Toxicology (2004)<br />
Vimpel, et al., The value of X-ray<br />
examination of the paranasal sinuses<br />
after epistaxis, Journal of Laryngology<br />
and Otology (1985)<br />
LWFR-EXP15-001984<br />
LWFR-EXP 15-001985-<br />
LWFR-EXP15-001991<br />
LWFR-EXP 15-001992-<br />
LWFR-EXP15-001993<br />
LWFR-EXP 15-001994-<br />
LWFR-EXP15-001999<br />
LWFR-EXP 15-002000-<br />
LWFR-EXP15-002003<br />
LWFR-EXP 15-002004-<br />
LWFR-EXP15-002015<br />
LWFR-EXP 15-002016-<br />
LWFR-EXP15-002049<br />
LWFR-EXP 15-002050-<br />
LWFR-EXP15-002060<br />
LWFR-EXP 15-002061-<br />
LWFR-EXP15-002071<br />
LWFR-EXP 15-002072-<br />
LWFR-EXP15-002079<br />
LWFR-EXP 15-002080-<br />
LWFR-EXP15-002087<br />
LWFR-EXP 15-002088-<br />
LWFR-EXP15-002094<br />
37
Von Bub<strong>no</strong>ff, et al., Dendric cells and<br />
atopic eczema/dermatitis syndrome, Skin<br />
and Eye<br />
Wahlberg, et al., Quantification and<br />
Specificity of the Repeated Open<br />
Application Test (ROAT), Acta Derm<br />
Venereol (1997)<br />
Wantke, et al., Formaldehyde and<br />
phe<strong>no</strong>l exposure during an anatomy<br />
dissection course: A possible source of<br />
IgE sensitization, Allergy (1996)<br />
Wantke, et al., Exposure to<br />
<strong>formaldehyde</strong> and phe<strong>no</strong>l during an<br />
dissecting course: sensitizing potency of<br />
<strong>formaldehyde</strong> in medical students,<br />
Allergy (2000)<br />
Wantke, et al., Exposure to<br />
<strong>formaldehyde</strong> and phe<strong>no</strong>l during<br />
anatomy dissecting course: sensitizing<br />
potency of <strong>formaldehyde</strong> in medical<br />
students, Allergy (2000)<br />
Ward, et al., A comparison of expression<br />
of surface-bound immu<strong>no</strong>globulin E on<br />
antigen-presenting cells in cutaneous<br />
tissue between patients with allergic,<br />
irritant and atopic dermatitis, Contact<br />
Dermatitis (1991)<br />
White, et al., Oral Tolerance to contact<br />
allergens: a common occurrence? A<br />
review, Contact Dermatitis (2007)<br />
Zaghi and Maibach, Quantitative<br />
Relationships Between Patch Test<br />
Reactivity and Use Test Reactivity: An<br />
Overview, Cutaneous and Ocular<br />
Toxicology (2008)<br />
Ziem and McTamney, Profile of Patients<br />
with Chemical Injury and Sensitivity,<br />
Environmental Health Perspectives<br />
(1997)<br />
Gibson, James, Formaldehdye Toxicity,<br />
(1983)<br />
88. Any and all articles identified and/or<br />
relied upon by Plaintiff and/or<br />
Defendant experts in the preparation of<br />
LWFR-EXP 15-002095-<br />
LWFR-EXP15-002100<br />
LWFR-EXP 15-002101-<br />
LWFR-EXP15-002106<br />
LWFR-EXP 15-002107-<br />
LWFR-EXP15-002112<br />
LWFR-EXP 15-002113-<br />
LWFR-EXP15-002117<br />
LWFR-EXP 15-002118-<br />
LWFR-EXP15-002122<br />
LWFR-EXP 15-002123-<br />
LWFR-EXP15-002130<br />
LWFR-EXP 15-002137-<br />
LWFR-EXP15-002145<br />
LWFR-EXP 15-002151-<br />
LWFR-EXP15-002160<br />
LWFR-EXP 15-002161-<br />
LWFR-EXP15-002176<br />
LWFR-EXP 15-002177-<br />
LWFR-EXP15-002178<br />
To be supplemented<br />
38
their reports.<br />
Expert<br />
Records and<br />
Files<br />
89. Affidavit and Weather Data of Lee E. LWFR-EXP1-000001 –<br />
Branscome, Ph.D., C.C.M.<br />
LWFR-EXP1-000122<br />
90. Curriculum Vitae of Lee E. Branscome,<br />
Ph.D., C.C.M.<br />
PSC 025205-<br />
PSC 025214<br />
92. Medical Records of Lyndon Wright and<br />
file of George Farber, M.D.<br />
LWFR-EXP2-000021 –<br />
LWFR-EXP2-000052<br />
93. Preliminary Report of Paul Hewett,<br />
Ph.D.<br />
LWFR-EXP3-000001 –<br />
LWFR-EXP3-000026<br />
Final Report of Paul Hewett, Ph.D. LWFR-EXP2-000027-<br />
LWFR-EXP2-000060<br />
Supplemental Report of Paul Hewitt, To be supplemented<br />
Ph.D. (to be produced)<br />
94. Curriculum Vitae of Paul Hewitt, Ph.D. PSC 025265-<br />
PSC 025269<br />
Paul Hewett August 20, 2008 Technical LWFR-EXP3-000170-<br />
Report in FEMA Formaldehyde LWFR-EXP3-000197<br />
Products Liability Litigation<br />
Paul Hewett Report for Gulf Stream / LWFR-EXP3-000198-<br />
Alexander Trial<br />
Letter from FEMA to Trailer Occupants<br />
Re: Formaldehyde levels found in their<br />
<strong>trailer</strong>s<br />
39<br />
LWFR-EXP3-000216<br />
PSC 019684-<br />
PSC 019692<br />
96. Deposition Testimony of Paul Hewett, To be supplemented<br />
Ph.D.<br />
98. Preliminary Report of Kenneth LWFR-EXP6-000001-<br />
Laughery, Ph.D.<br />
LWFR-EXP6-000006<br />
Final Report of Kenneth Laughery,<br />
Ph.D.<br />
LWFR-EXP6-000007-<br />
LWFR-EXP6-000013<br />
99. Curriculum Vitae of Kenneth Laughery,<br />
Ph.D.<br />
PSC 025282-<br />
PSC 025313<br />
103. Preliminary Report of Alexis Mallet, Jr. LWFR-EXP7-000001-<br />
LWFR-EXP7-000013<br />
Final Report of Alexis Mallet, Jr. LWFR-EXP7-000014-<br />
LWFR-EXP7-000144<br />
Photographs for Report of Alexis Mallet,<br />
Jr.<br />
LWFR-EXP7-000145-<br />
LWFR-EXP7-000184<br />
104. Curriculum Vitae of Alexis Mallet, Jr. PSC 025314-<br />
PSC 025324<br />
Alexis Mallet, Jr., emails re discussion LWFR-EXP7-009495-<br />
of Parish Permit<br />
LWFR-EXP7-009497
Alexis Mallet, Jr., emails re Newspaper<br />
Article on Orleans Parish Electrical<br />
Codes<br />
Letter from Blanco to Thomas, 09/23/05<br />
Alexis Mallet emails and attached letters<br />
concerning Permit Regulations in<br />
Orleans Parish<br />
Policies and Code Clarifications<br />
Shaw Daily Quality Control Report,<br />
11/29/05<br />
Shaw emails regarding Orleans Parish<br />
Permit and Code Requirements<br />
Mach 15 RV Air Condition<br />
RVP Installation Instructions for 8000<br />
Series Air Conditioners<br />
RVP Operation and Maintenance<br />
Instructions for 6000, 7000, and 8000<br />
Series Air Conditioners<br />
RVP Data Inquiry Sheet<br />
FEMA-Dubuclet Report 7/14/09<br />
Email from Wyatt Rankin to Alex<br />
Mallet, 5/19/09<br />
Bayseal CC<br />
Bayseal CC for Residential Builders<br />
Chemical Design, Closed Cell Spray<br />
Foam<br />
Green Home Builder Creates<br />
Environmentally Friendly Home with<br />
Closed Cell Foam<br />
EnviroFoam Insulation<br />
Dometic Installation Instructions<br />
Forest River Appliance Information<br />
Sheet<br />
Emails regarding Fluor Jacking<br />
Instructions<br />
40<br />
LWFR-EXP7-009503-<br />
LWFR-EXP7-009526<br />
LWFR-EXP7-009527-<br />
LWFR-EXP7-009545<br />
LWFR-EXP7-009503-<br />
LWFR-EXP7-009526<br />
LWFR-EXP7-009546-<br />
LWFR-EXP7-009547<br />
LWFR-EXP7-009548-<br />
LWFR-EXP7-009551<br />
LWFR-EXP7-009552<br />
LWFR-EXP7-009553-<br />
LWFR-EXP7-009554<br />
LWFR-EXP7-009555-<br />
LWFR-EXP7-009570<br />
LWFR-EXP7-009571-<br />
LWFR-EXP7-009578<br />
LWFR-EXP7-009579-<br />
LWFR-EXP7-009580<br />
LWFR-EXP7-009581-<br />
LWFR-EXP7-009582<br />
LWFR-EXP7-009602<br />
LWFR-EXP7-009603-<br />
LWFR-EXP7-009604<br />
LWFR-EXP7-009605-<br />
LWFR-EXP7-009606<br />
LWFR-EXP7-009607-<br />
LWFR-EXP7-009611<br />
LWFR-EXP7-009612-<br />
LWFR-EXP7-009613<br />
LWFR-EXP7-009614-<br />
LWFR-EXP7-009621<br />
LWFR-EXP7-009583-<br />
LWFR-EXP7-009601<br />
LWFR-EXP7-009614-<br />
LWFR-EXP7-009622<br />
LWFR-EXP7-009643-<br />
LWFR-EXP7-009644
Fluor FEMA Procedures<br />
LWFR-EXP7-009645-<br />
LWFR-EXP7-009655<br />
Important Information for Travel Trailer<br />
Occupants<br />
LWFR-EXP7-009656-<br />
LWFR-EXP7-009657<br />
Formaldehyde Levels in FEMA- LWFR-EXP7-009658-<br />
Supplied Trailers<br />
LWFR-EXP7-009659<br />
Suburban Gas Furnaces Installation LWFR-EXP7-009660-<br />
Instruction<br />
LWFR-EXP7-009688<br />
Emails regarding CH20 Information LWFR-EXP7-009689<br />
Information from Composite Panel LWFR-EXP7-009690-<br />
Association Website<br />
LWFR-EXP7-009708<br />
Maxx Fan Installation Instructions LWFR-EXP7-009709-<br />
LWFR-EXP7-009713<br />
Emails regarding Closed Cell Foam LWFR-EXP7-009714-<br />
LWFR-EXP7-009717<br />
Versi-Foam Systems<br />
LWFR-EXP7-009718-<br />
LWFR-EXP7-009732<br />
Chemical Design Product Catalog: LWFR-EXP7-009733-<br />
Closed Cell Spray Foam<br />
LWFR-EXP7-009747<br />
Tool Box Training: Proper Jacking LWFR-EXP7-009748<br />
Techniques<br />
Emails Regarding Shaw Jacking LWFR-EXP7-009749-<br />
Procedure<br />
LWFR-EXP7-009750<br />
MHRA Website on Moisture Field<br />
Study<br />
LWFR-EXP7-009751-<br />
LWFR-EXP7-009752<br />
MHRA Minimizing Moisture Problems LWFR-EXP7-009753-<br />
Report<br />
LWFR-EXP7-009799<br />
MHRA Report Page with Handwritten LWFR-EXP7-009800-<br />
Note<br />
LWFR-EXP7-009801<br />
Building your Louisiana House LWFR-EXP7-009802-<br />
LWFR-EXP7-009804<br />
Email regarding Gulf Stream Coach<br />
Construction<br />
LWFR-EXP7-009805-<br />
LWFR-EXP7-009806<br />
RESNET Standards Chapter Seven LWFR-EXP7-009850-<br />
LWFR-EXP7-009877<br />
RESNET National Home Energy Rating<br />
Technical Guidelines 12/28/05<br />
LWFR-EXP7-009878-<br />
LWFR-EXP7-009918<br />
Performance Work Statement: LWFR-EXP7-009927-<br />
Individual Assistance-Technical LWFR-EXP7-009945<br />
Assistance Contract<br />
Email from Alexis Mallet to Alexis LWFR-EXP7-009958-<br />
Mallet regarding Electronic Code of LWFR-EXP7-009959<br />
Federal Regulations<br />
Stephen Patterson and Madan Mahta, LWFR-EXP7-009960-<br />
41
Roofing Design and Practice<br />
Email from Orleans Parish re: Code<br />
Enforcement<br />
106. Trailer drawings by Alexis Mallet,<br />
Jr./Ervin Ritter<br />
Trailer Photographs by Alexis Mallet, Jr.<br />
Trailer Videos by Alexis Mallet, Jr.<br />
Trailer Images by Alexis Mallet, Jr.<br />
Data Logger Information by Alexis<br />
Mallet, Jr.<br />
42<br />
LWFR-EXP7-009962<br />
LWFR-EXP7-13951<br />
LWFR-EXP7-13933-<br />
LWFR-EXP7-13950<br />
LWFR-EXP7-004671-<br />
LWFR-EXP7-005396;<br />
LWFR-EXP7-005401-<br />
LWFR-EXP7-005513;<br />
LWFR-EXP7-005518-<br />
LWFR-EXP7-005546;<br />
LWFR-EXP7-005554-<br />
LWFR-EXP7-005571;<br />
LWFR-EXP7-005574-<br />
LWFR-EXP7-005725;<br />
LWFR-EXP7-005726-<br />
LWFR-EXP7-006465;<br />
LWFR-EXP7-010628-<br />
LWFR-EXP7-010942;<br />
LWFR-EXP7-010999-<br />
LWFR-EXP7-011539;<br />
LWFR-EXP7-011541-<br />
LWFR-EXP7-011629;<br />
LWFR-EXP7-011660-<br />
LWFR-EXP7-011661;<br />
LWFR-EXP7-011749-<br />
LWFR-EXP7-011816;<br />
LWFR-EXP7-011822-<br />
LWFR-EXP7-012292;<br />
LWFR-EXP7-012782-<br />
LWFR-EXP7-013440;<br />
LWFR-EXP7-013441-<br />
LWFR-EXP7-013932<br />
LWFR-EXP7-005397;<br />
LWFR-EXP7-005398;<br />
LWFR-EXP7-005399;<br />
LWFR-EXP7-005400;<br />
LWFR-EXP7-008043-<br />
LWFR-EXP7-009430<br />
1 LWFR-EXP7-012293-<br />
1 LWFR-EXP7-012370;<br />
2 LWFR-EXP7-012371-<br />
2 LWFR-EXP7-012448;<br />
3 LWFR-EXP7-012449-<br />
3 LWFR-EXP7-012522;
4 LWFR-EXP7-012523-<br />
4 LWFR-EXP7-012600;<br />
5 LWFR-EXP7-012601-<br />
5 LWFR-EXP7-012678;<br />
6 LWFR-EXP7-012679-<br />
6 LWFR-EXP7-012756<br />
Ritter Consulting Engineers Handwritten<br />
Notes<br />
LWFR-EXP7-011817-<br />
LWFR-EXP7-011821<br />
109. Preliminary Report of Lawrence G.<br />
Miller, M.D., M.P.H.<br />
LWFR-EXP8-000001-<br />
LWFR-EXP8-000009<br />
Final Report of Lawrence G. Miller, LWFR-EXP8-000010<br />
M.D., M.P.H.<br />
LWFR-EXP8-000019<br />
Supplemental Report of Lawrence G. LWFR-EXP8-000108-<br />
Miller, M.D., M.P.H.<br />
LWFR-EXP8-000109<br />
110. Curriculum Vitae of Lawrence G.<br />
Miller, M.D., M.P.H.<br />
PSC 025360-<br />
PSC 025375<br />
Temporary Medical License for Dr. To be supplemented<br />
Lawrence Miller<br />
113. Exhibits from the deposition of To be supplemented<br />
Lawrence G. Miller, M.D., M.P.H.<br />
114. Preliminary Report of Charles David LWFR-EXP9-000001-<br />
Moore, P.E. P.L.S.<br />
LWFR-EXP9-000004<br />
Final Report of Charles David Moore, LWFR-EXP5-000005-<br />
P.E. P.L.S.<br />
LWFR-EXP5-000042<br />
115. Curriculum Vitae of Charles David<br />
Moore, P.E. P.L.S.<br />
PSC 025346-<br />
PSC 025349<br />
Construction Manuals (Manual of Steel LWFR-EXP5-000457-<br />
Construction, Minimum Design Loads, LWFR-EXP5-000459<br />
Timber Construction Manual)<br />
119. Preliminary Report of Ervin Ritter, P.E. LWFR-EXP10-000001-<br />
LWFR-EXP10-000007<br />
Final Report of Ervin Ritter, P.E. LWFR-EXP10-000008-<br />
LWFR-EXP10-000117<br />
120. Curriculum Vitae of Ervin Ritter, P.E. PSC 025350-<br />
PSC 025354<br />
121. Reliance Materials and File of Ervin To be supplemented<br />
Ritter, P.E.<br />
122. Deposition Testimony of Ervin Ritter, To be supplemented<br />
P.E.<br />
123. Exhibits from the deposition of Ervin To be supplemented<br />
Ritter, P.E.<br />
All photographs by Ervin Ritter LWFR-EXP10-000118-<br />
LWFR-EXP10-002068<br />
124. Preliminary Report of William D. Scott, LWFR-EXP11-000001-<br />
43
P.E., C.H.M.M.<br />
LWFR-EXP11-000042<br />
Final Report of William D. Scott, P.E., LWFR-EXP11-000043-<br />
C.H.M.M.<br />
LWFR-EXP11-000135<br />
125. Curriculum Vitae of William D. Scott, PSC 025355-<br />
P.E., C.H.M.M.<br />
PSC 025368<br />
126. Reliance Materials and File of William To be supplemented<br />
D. Scott, P.E., C.H.M.M.<br />
127. Deposition Testimony of William D. To be supplemented<br />
Scott, P.E. C.H.M.M.<br />
128. Exhibits from the deposition of William To be supplemented<br />
D. Scott, P.E., C.H.M.M.<br />
129. Microbial Growth Report by W.D. Scott To be supplemented<br />
and Associates<br />
130. Preliminary Report of Edward H. LWFR-EXP12-000001-<br />
Shwery, Ph.D.<br />
LWFR-EXP12-000011<br />
Preliminary Report of Edward H. LWFR-EXP12-000012-<br />
Shwery, Ph.D.<br />
LWFR-EXP12-000016<br />
131. Curriculum Vitae of Edward H. Shwery,<br />
Ph.D.<br />
PSC 025369-<br />
PSC 025391<br />
Edward H. Shwery Testing Raw Data LWFR-EXP12-000061-<br />
and Notes<br />
LWFR-EXP12-000128<br />
132. Reliance Materials and File of Edward To be supplemented<br />
H. Shwery, Ph.D.<br />
133. Deposition Testimony of Edward H. To be supplemented<br />
Shwery, Ph.D.<br />
134. Exhibits from the deposition of Edward To be supplemented<br />
H. Shwery, Ph.D.<br />
135. Preliminary Report of Stephen Smulski,<br />
Ph.D.<br />
LWFR-EXP13-000001-<br />
LWFR-EXP13-000022<br />
Final Report of Stephen Smulski, Ph.D. LWFR-EXP13-000023-<br />
LWFR-EXP13-000061<br />
136. Curriculum Vitae of Stephen Smulski, PSC 025392-<br />
Ph.D.<br />
PSC 025406<br />
Emails between Stephen Smulski and To be supplemented<br />
Composite Panel Association<br />
137. Reliance Materials and File of Stephen To be supplemented<br />
Smulski, Ph.D.<br />
Additional Reliance Documents, <strong>no</strong>t yet To be supplemented<br />
produced by Stephen Smulski, Ph.D.<br />
Photographs by Stephen Smulski, Ph.D. LWFR-EXP13-004164<br />
LWFR-EXP13-004354<br />
138. Deposition Testimony of Stephen To be supplemented<br />
Smulski, Ph.D.<br />
139. Exhibits from the deposition of Stephen To be supplemented<br />
44
Smulski, Ph.D.<br />
140. Preliminary Report of Patricia M. LWFR-EXP15-000001-<br />
Williams, Ph.D. D.A.B.T.<br />
LWFR-EXP15-000054<br />
Final Report of Patricia M. Williams, LWFR-EXP15-000055-<br />
Ph.D., D.A.B.T.<br />
LWFR-EXP15-000130<br />
141. Curriculum Vitae of Patricia M. PSC 025407-<br />
Williams, Ph.D., D.A.B.T.<br />
PSC 025437<br />
Fee Schedule of Patricia M. Williams, PSC 025438<br />
Ph.D., D.A.B.T.<br />
List of Testimonies of Patricia M.<br />
Williams, Ph.D., D.A.B.T.<br />
PSC 025439-<br />
PSC 025440<br />
142. Reliance Material and File of Patricia M. To be supplemented<br />
Williams, Ph.D., D.A.B.T.<br />
143. Deposition Testimony of Patricia M. To be supplemented<br />
Williams, Ph.D., D.A.B.T.<br />
144. Exhibits from the deposition of Patricia To be supplemented<br />
M. Williams, Ph.D., D.A.B.T.<br />
145. Preliminary Report of Paul LaGrange LWFR-EXP5-000001-<br />
LWFR-EXP5-000002<br />
Final Report of Paul LaGrange<br />
LWFR-EXP5-000003-<br />
LWFR-EXP5-000316<br />
Supplemental Report of Paul LaGrange To be supplemented<br />
146. Curriculum Vitae of Paul LaGrange PSC 026031-<br />
PSC 026034<br />
Fee Schedule of Paul LaGrange PSC 026035<br />
List of Testimonies of Paul LaGrange PSC 026036<br />
147. Reliance Materials and File of Paul To be supplemented<br />
LaGrange<br />
Additional Documents of Paul LaGrange LWFR-EXP5-000317-<br />
LWFR-EXP5-000570<br />
Photographs by Paul LaGrange LWFR-EXP5-000595-<br />
LWFR-EXP5-001243;<br />
LWFR-EXP5-001244-<br />
LWFR-EXP5-001271<br />
Videos by Paul LaGrange<br />
LWFR-EXP5-000572;<br />
LWFR-EXP5-000575;<br />
LWFR-EXP5-000573;<br />
LWFR-EXP5-000574;<br />
LWFR-EXP5-000578<br />
Initial Place Holding Report<br />
LWFR-EXP5-000576-<br />
LWFR-EXP5-000577<br />
Paul LaGrange Handwritten Notes; LWFR-EXP5-000579-<br />
Inspection Notes<br />
LWFR-EXP5-000594<br />
LaGrange Report LWFR-EXP 5-000001 –<br />
45
LWFR-EXP 5-000316;<br />
PSC 026031 –<br />
PSC 026036<br />
Dometic Installation Instructions FR-LTW-EXP06-107751<br />
–<br />
FR-LTW-EXP06-107769<br />
LaGrange Video Animation with You LWFR-EXP 5-001277<br />
Tube link<br />
LaGrange HVAC Load Calculations<br />
(Corrected Manual J Load)<br />
LWFR-EXP 5-001278 –<br />
LWFR-EXP 5-001296<br />
LaGrange Supplemental Letter of<br />
Clarification<br />
LWFR-EXP 5-001272 –<br />
LWFR-EXP 5-001273<br />
LaGrange Tectite Blower Door Test<br />
Report<br />
LWFR-EXP 5-001274 –<br />
LWFR-EXP 5-001276<br />
148. Deposition Testimony of Paul LaGrange To be supplemented<br />
149. Exhibits from the deposition of Paul To be supplemented<br />
LaGrange<br />
150. Preliminary Report of Dr. Richard A LWFR-EXP14-000001-<br />
Spector<br />
LWFR-EXP14-000004<br />
Final Report of Dr. Richard A. Spector LWFR-EXP14-000005-<br />
LWFR-EXP14-000015<br />
151. Curriculum Vitae of Dr. Richard A. PSC 026027-<br />
Spector<br />
PSC 026030<br />
152. Reliance Materials and File of Dr. To be supplemented<br />
Richard A. Spector<br />
153. Deposition Testimony of Dr. Richard A. To be supplemented<br />
Spector<br />
154. Exhibits from the deposition of Dr. To be supplemented<br />
Richard A. Spector<br />
155. Any supplemental Affidavits or Reliance To be supplemented<br />
Material by Plaintiff’s or Defendants’<br />
Experts<br />
156. Any deposition testimony provided by To be supplemented<br />
any and all plaintiff and/or deposition<br />
fact and/or expert witness in this matter.<br />
157. Any and all demonstrative evidence to To be supplemented<br />
be developed and/or utilized by<br />
Plaintiff’s experts at trial<br />
158. Any additional exhibits identified at To be supplemented<br />
deposition of any expert or fact witness<br />
in this matter.<br />
Any document to be identified by<br />
Plaintiff in the ongoing discovery and<br />
deposition process<br />
To be supplemented<br />
46
All Photographs taken by Plaintiff or<br />
Plaintiff’s Experts<br />
Any Plaintiff supplementation of any<br />
report and supplementing documents<br />
which may occur<br />
Any and all Plaintiff demonstrative aids<br />
for trial to be exchanged at the<br />
appropriate time<br />
Testing<br />
Database<br />
159. Formaldehyde Testing Database<br />
Testing<br />
Documents<br />
prepared by the PSC<br />
Bill Scott Testing Data, October, 2008<br />
Bill Scott Testing Data, August, 2009<br />
Mold Testing Data<br />
Plaintiff’s Testing Protocol<br />
All Testing Results Produced Relating to<br />
Lyndon Wright Unit<br />
Inspection in<br />
Melville, LA<br />
160. Photographs taken by<br />
Plaintiffs/Plaintiff’s Experts during<br />
destructive testing at FEMA<br />
Staging/Storing Facility in Melville,<br />
Louisiana.<br />
161. Video taken by Plaintiff/Plaintiff’s<br />
Experts during the destructive testing at<br />
FEMA Staging/Storage Facility in<br />
Melville, Louisiana.<br />
162. Photographs taken by<br />
Defendants/Defendants’ Experts during<br />
destructive testing.<br />
163. Video taken by Defendants/Defendants’<br />
Experts during destructive testing.<br />
164. Animations created by C4 Animation<br />
(Reagan Johnson)<br />
166. Results of all testing and inspection of<br />
the Forest River/Wright unit including,<br />
but <strong>no</strong>t limited to, air sampling,<br />
temperature, humidity, and photographs<br />
thereof<br />
47<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
168. Test Results of mold sampling To be supplemented
performed by WD Scott Group during<br />
destructive testing.<br />
169. Test Results of mold sampling taken by<br />
Defendants’ Experts during destructive<br />
testing.<br />
171. Exemplar of a Personal Monitoring<br />
System for Aldehydes (Exemplar<br />
Passive Dosimeter)<br />
172. Exemplars of Various Component Wood<br />
Products from Lyndon Wright Forest<br />
River Travel Trailer.<br />
173. Exemplars of Alternative Wood<br />
Products from Lyndon Wright Forest<br />
River Travel Trailer.<br />
174. All additional measurements to<br />
measurements and graphic<br />
representations of Lyndon Wright <strong>trailer</strong><br />
to be identified<br />
Forest River,<br />
Inc.<br />
175. Forest River, Inc., Lyndon Wright <strong>trailer</strong><br />
unit file<br />
176. Any and all Class certification Forest<br />
River deposition testimony<br />
177. Any and all Class certification Forest<br />
River deposition exhibits / documents<br />
produced<br />
48<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
FR-0151924<br />
FR-151946<br />
To be supplemented<br />
To be supplemented<br />
178. Forest River Owner’s Manual FOREST 0002399-<br />
FOREST 0002483<br />
Forest River Draft Testing Protocol<br />
FR-LTW-EXP06-06698-<br />
FR-LTW-EXP06-006701<br />
179. FEMA Specifications FOREST 0003284-<br />
FOREST 0003289<br />
180. NACS Correspondence and Solicitation FOREST 0002503-<br />
and emails<br />
FOREST 0002508;<br />
181. Any and all Internal emails and<br />
communications relevant to FEMA<br />
production<br />
Liberty Building Emails<br />
FOREST 0003521<br />
To be supplemented<br />
FR-LTW-EXP06-<br />
019602;<br />
FR-LTW-EXP06-<br />
019676-<br />
FR-LTW-EXP06-
Email between John Odom and Don<br />
Snell 10/22/09 (Exhibit 20 of Liberty<br />
Deposition)<br />
ANSI/ASHRAE Standard 62.2-2004, pp.<br />
9-10<br />
49<br />
019678;<br />
FR-LTW-EXP06-<br />
019631-<br />
FR-LTW-EXP06-<br />
019634;<br />
FR-LTW-EXP06-<br />
019688-<br />
FR-LTW-EXP06-<br />
019698;<br />
FR-LTW-EXP06-<br />
019648-<br />
FR-LTW-EXP06-<br />
019653;<br />
FR-LTW-EXP06-<br />
019637-<br />
FR-LTW-EXP06-<br />
019644;<br />
FR-LTW-EXP06-<br />
019609-<br />
FR-LTW-EXP06-<br />
019616;<br />
FR-LTW-EXP06-<br />
019603-<br />
FR-LTW-EXP06-019608<br />
To be supplemented<br />
FR-LTW-EXP06-<br />
006498-<br />
FR-LTW-EXP06-006499<br />
To be supplemented<br />
182. Any and all Deposition Testimony of<br />
Elton Kiefer<br />
183. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Elton Kiefer<br />
184. Any and all Deposition Testimony of To be supplemented<br />
Jeff Burrian<br />
185. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Jeff Burrian<br />
186. Affidavits of Norman Nelson To be supplemented<br />
187. Curriculum Vitae of Norman Nelson FR-LTW-EXP06-<br />
019726-<br />
188. Reliance Materials and File of Norman<br />
Nelson<br />
FR-LTW-EXP06-019729<br />
To be supplemented
189. Any and all Deposition Testimony of To be supplemented<br />
Norman Nelson<br />
190. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Norman Nelson<br />
191. Report of G. Graham Allan LTW-EXP01-000001-<br />
LTW-EXP01-000003<br />
192. Curriculum Vitae of G. Graham Allan LTW-EXP01-000004-<br />
LTW-EXP01-000036<br />
Fee Schedule of G. Graham Allen LTW-EXP01-000037<br />
List of Testimonies of G. Graham Allen LTW-EXP01-000038<br />
193. Reliance Materials and File of G. To be supplemented<br />
Graham Allan<br />
194. Any and all Deposition Testimony of G. To be supplemented<br />
Graham Allan<br />
195. Any and all Exhibits from the To be supplemented<br />
deposition(s) of G. Graham Allan<br />
196. Report of Philip Cole, M.D. FR-LTW-EXP02-<br />
000001-<br />
FR-LTW-EXP02-000020<br />
Report of Philip Cole, M.D.<br />
FR-LTW-EXP02-<br />
000041-<br />
FR-LTW-EXP02-000060<br />
197. Curriculum Vitae of Philip Cole, M.D. FR-LTW-EXP02-<br />
000021-<br />
FR-LTW-EXP02-000037<br />
List of Testimonies of Philip Cole, M.D. FR-LTW-EXP02-000038<br />
FR-LTW-EXP02-000040<br />
198. Reliance Materials and File of Philip To be supplemented<br />
Cole, M.D.<br />
199. Any and all Deposition Testimony of To be supplemented<br />
Philip Cole, M.D.<br />
200. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Philip Cole, M.D.<br />
201. Affidavits of Nathan T. Dorris To be supplemented<br />
202. Curriculum Vitae of Nathan T. Dorris FR-LTW-EXP03-<br />
000001-<br />
FR-LTW-EXP03-000015<br />
203. Reliance Materials and File of Nathan T. To be supplemented<br />
Dorris<br />
204. Any and all Deposition Testimony of To be supplemented<br />
Nathan T. Dorris<br />
205. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Nathan T. Dorris<br />
206. Report of William L. Dyson FR-LTW-EXP04-<br />
50
000001-<br />
FR-LTW-EXP04-000019<br />
207. Curriculum Vitae of William L. Dyson FR-LTW-EXP04-<br />
000020-<br />
FR-LTW-EXP04-000023<br />
Fee Schedule of William L. Dyson<br />
List of Testimonies of Williams L.<br />
Dyson<br />
208. Reliance Materials and File of William<br />
L. Dyson<br />
51<br />
FR-LTW-EXP04-000024<br />
FR-LTW-EXP04-<br />
000025-<br />
FR-LTW-EXP04-000031<br />
FR-LTW-EXP04-<br />
000001-<br />
FR-LTW-EXP04-000567<br />
209. Any and all Deposition Testimony of To be supplemented<br />
William L. Dyson<br />
210. Any and all Exhibits from the To be supplemented<br />
deposition(s) of William L. Dyson<br />
211. Report of Thomas Fribley FR-LTW-EXP05-<br />
000001-<br />
FR-LTW-EXP05-000003<br />
212. Curriculum Vitae of Thomas Fribley FR-LTW-EXP05-<br />
000004-<br />
FR-LTW-EXP05-000008<br />
213. Reliance Materials and File of Thomas<br />
Fribley<br />
FR-LTW-EXP05-<br />
000001-<br />
FR-LTW-EXP05-001454<br />
214. Any and all Deposition Testimony of To be supplemented<br />
Thomas Fribley<br />
215. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Thomas Fribley<br />
216. Affidavits of Don Snell To be supplemented<br />
217. Curriculum Vitae of Don Snell FR-LTW-EXP06-<br />
019731-<br />
FR-LTW-EXP06-019735<br />
218. Reliance Materials and File of Don Snell To be supplemented<br />
219. Any and all Deposition Testimony of To be supplemented<br />
Don Snell<br />
220. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Don Snell<br />
221. Affidavits of Kenneth B. Smith To be supplemented<br />
222. Curriculum Vitae of Kenneth B. Smith LTW-EXP07-000001-<br />
LTW-EXP07-000002<br />
Fee Schedule of Kenneth B. Smith LTW-EXP07-000003-<br />
LTW-EXP07-000004<br />
223. Reliance Materials and File of Kenneth LTW-EXP07-000001-
B. Smith LTW-EXP07-000291<br />
224. Any and all Deposition Testimony of To be supplemented<br />
Kenneth B. Smith<br />
225. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Kenneth B. Smith<br />
226. Report of Dr. John W. Thompson FR-LTW-EXP08-<br />
000001-<br />
FR-LTW-EXP08-000015<br />
227. Curriculum Vitae of Dr. John W.<br />
Thompson<br />
FR-LTW-EXP08-<br />
000016-<br />
List of Testimonies of Dr. John W.<br />
Thompson<br />
Fee Schedule of Dr. John W. Thompson<br />
228. Reliance Materials and File of Dr. John<br />
W. Thompson<br />
52<br />
FR-LTW-EXP08-000037<br />
FR-LTW-EXP08-<br />
000038-<br />
FR-LTW-EXP08-000052<br />
FR-LTW-EXP08-000053<br />
FR-LTW-EXP08-<br />
000001-<br />
FR-LTW-EXP08-002293<br />
229. Any and all Deposition Testimony of Dr. To be supplemented<br />
John W. Thompson<br />
230. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Dr. John W. Thompson<br />
231. Affidavits of Tony Watson To be supplemented<br />
232. Curriculum Vitae of Tony Watson FR-LTW-EXP09-<br />
000169-<br />
FR-LTW-EXP09-000170<br />
FR-LTW-EXP09-000171<br />
List of Trial Testimonies of Tony<br />
Watson<br />
233. Reliance Materials and File of Tony To be supplemented<br />
Watson<br />
234. Any and all Deposition Testimony of To be supplemented<br />
Tony Watson<br />
235. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Tony Watson<br />
236. Affidavits of H. James Wedner, M.D. Bates Range to be<br />
supplied upon receipt of<br />
same<br />
237. Curriculum Vitae of H. James Wedner,<br />
M.D.<br />
238. Reliance Materials and File of H. James<br />
Wedner, M.D.<br />
Bates Range to be<br />
supplied upon receipt of<br />
same<br />
Bates Range to be<br />
supplied upon receipt of<br />
same<br />
239. Any and all Deposition Testimony of H. To be supplemented
James Wedner, M.D.<br />
240. Any and all Exhibits from the To be supplemented<br />
deposition(s) of H. James Wedner, M.D.<br />
241. Any and all Deposition Testimony of To be supplemented<br />
Jaime Albrecht<br />
242. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Jaime Albrecht<br />
243. Any and all Deposition Testimony of To be supplemented<br />
Jim Foltz<br />
244. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Jim Foltz<br />
245. Any and all Deposition Testimony of To be supplemented<br />
Forest River Warranty Officer, yet to be<br />
designated<br />
246. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Forest River Warranty<br />
Deponent, yet to be designated<br />
247. Any and all Deposition Testimony of To be supplemented<br />
Corporate Representative of Forest<br />
River, Doug Gaeddert<br />
248. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Corporate<br />
Representative of Forest River, Doug<br />
Gaeddert<br />
249. Any and all Deposition Testimony of To be supplemented<br />
any and/or all Corporate Representative<br />
of Forest River, yet to be designated<br />
250. Any and all Exhibits from the To be supplemented<br />
deposition(s) of any and/or all Corporate<br />
Representative of Forest River, yet to be<br />
designated<br />
251. Any and all documentation identified by To be supplemented<br />
defendant’s experts in the preparation of<br />
their reports and/or testimony.<br />
252. Any and all exhibits identified and/or To be supplemented<br />
used and/or relied upon by defendant’s<br />
in the ongoing litigation of this matter.<br />
Pricing costs for 32 BHLE FOREST 0003171-<br />
FOREST 0003249<br />
32 BHLE Diagrams and Specs FOREST 0003250-<br />
FOREST 0003299;<br />
FOREST 0003366-<br />
FOREST 0003391<br />
Lippert 32 BHLE Diagrams FOREST 0003140;<br />
53
FOREST 0003344-<br />
FOREST 0003345;<br />
FOREST 0003351<br />
Any and all blueprints and design To be supplemented<br />
documents produced at deposition<br />
255. Internal Forest River Memorandum FOREST 0003294-<br />
regarding proposed production schedule FOREST 0003299<br />
256. September 1, 2005, NACS/FEMA To be supplemented<br />
Solicitation and Specifications<br />
257. Handwritten designs, drawings, and To be supplemented<br />
<strong>no</strong>tes for FEMA units<br />
258. NACS/Forest River FEMA To be supplemented<br />
Specifications documents<br />
259. 2004 Email from NACS to Forest River To be supplemented<br />
regarding FEMA Trailer Production<br />
Specifications<br />
260. November 2006 Elton Kiefer <strong>no</strong>tes To be supplemented<br />
regarding Patrick and Adorn switching<br />
to LFE in early 2007<br />
261. September 1, 2005 email Ty Miller to To be supplemented<br />
Doug Gaeddert and Tom Martin<br />
regarding California production<br />
Deposition Transcript of Brian Deckle, P. 79-81<br />
NACS<br />
Warranty Documents and Repair To be supplemented<br />
Documents<br />
MSDS’s FOREST 0002609-<br />
FOREST 0002619<br />
Congressional Statement of Pete Liegl To be supplemented<br />
September 1, 2005, Production FOREST 0003449<br />
Memorandum<br />
Forest River’s responses to Discovery To be supplemented<br />
Requests<br />
Forest River Inspection Protocol To be supplemented<br />
Forest River Testing Methodologies FR-LTW-EXP06-006696<br />
from Liberty (Operational Pressures)<br />
Forest River Testing Methodologies<br />
from Liberty (Testing Methodologies)<br />
FR-LTW-EXP06-<br />
003857-<br />
FR-LTW-EXP06-003862<br />
Forest River Periodic Maintenance Chart FR-LTW-EXP06-017924<br />
Liberty Handwritten <strong>no</strong>tes starting FR-LTW-EXP06-<br />
07/30/09<br />
004902-<br />
FR-LTW-EXP06-004920<br />
Liberty Schematics of Trailer<br />
FR-LTW-EXP06-<br />
54
Billing records of all Forest River<br />
Defense Experts<br />
All photographs taken by Forest River<br />
and/or Forest River’s Experts<br />
Any document to be identified by<br />
Defendant Forest River in the ongoing<br />
discovery and deposition process<br />
Any Forest River supplementation of<br />
any report and supplementing documents<br />
which may occur<br />
Any and all Forest River demonstrative<br />
aids for trial to be exchanged at the<br />
appropriate time<br />
U.S.A.<br />
262. U.S.A. / FEMA Disaster File for Bobbi<br />
Wright and/or Lyndon Wright<br />
55<br />
017166;<br />
FR-LTW-EXP06-<br />
017925-<br />
FR-LTW-EXP06-017931<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
FEMA 124-000001-<br />
FEMA 124-000078<br />
263. Affidavits of Robert James, Ph.D. To be supplemented<br />
264. Curriculum Vitae of Robert James, To be supplemented<br />
Ph.D.<br />
265. Reliance Materials and File of Robert To be supplemented<br />
James, Ph.D.<br />
266. Any and all Deposition Testimony of To be supplemented<br />
Robert James, Ph.D.<br />
267. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Robert James, Ph.D.<br />
268. Affidavits of Bruce Kelman, Ph.D. To be supplemented<br />
269. Curriculum Vitae of Bruce Kelman, To be supplemented<br />
Ph.D.<br />
270. Reliance Materials and File of Bruce To be supplemented<br />
Kelman, Ph.D.<br />
271. Any and all Deposition Testimony of To be supplemented<br />
Bruce Kelman, Ph.D.<br />
272. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Bruce Kelman, Ph.D.<br />
273. Affidavits of Michael Lindell, Ph.D. To be supplemented<br />
274. Curriculum Vitae of Michael Lindell, To be supplemented<br />
Ph. D.<br />
275. Reliance Materials and File of Michael To be supplemented<br />
Lindell, Ph.D.<br />
276. Any and all Deposition Testimony of To be supplemented
Michael Lindell, Ph.D.<br />
277. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Michael Lindell, Ph.D.<br />
278. Affidavits of Richard Monson, M.D., To be supplemented<br />
Sc.D.<br />
279. Curriculum Vitae of Richard Monson, To be supplemented<br />
M.D., Sc.D.<br />
280. Reliance Materials and File of Richard To be supplemented<br />
Monson, M.D., Sc.D.<br />
281. Any and all Deposition Testimony of To be supplemented<br />
Richard Monson, M.D., Sc.D.<br />
282. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Richard Monson, M.D.,<br />
Sc.D.<br />
283. Affidavits of Mark Polk To be supplemented<br />
284. Curriculum Vitae of Mark Polk To be supplemented<br />
285. Reliance Materials and File of Mark To be supplemented<br />
Polk<br />
286. Any and all Deposition Testimony of To be supplemented<br />
Mark Polk<br />
287. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Mark Polk<br />
288. Affidavits of Coreen Robbins, M.H.S., To be supplemented<br />
Ph.D., C.I.H.<br />
289. Curriculum Vitae of Coreen Robbins, To be supplemented<br />
M.H.S., Ph.D., C.I.H.<br />
290. Reliance Materials and File of Coreen To be supplemented<br />
Robbins, M.H.S., Ph.D., C.I.H.<br />
291. Any and all Deposition Testimony of To be supplemented<br />
Coreen Robbins, M.H.S., Ph.D., C.I.H.<br />
292. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Coreen Robbins,<br />
M.H.S., Ph.D., C.I.H.<br />
293. Any and all Deposition Testimony of Dr. To be supplemented<br />
Christopher DeRosa<br />
294. Any and all Exhibits from the To be supplemented<br />
deposition(s) of Dr. Christopher DeRosa<br />
295. FEMA Storage Site<br />
To be supplemented<br />
Duties/Responsibilities regarding Forest<br />
River, Inc.<br />
296. FEMA Model Travel Trailer<br />
To be supplemented<br />
Procurement Specifications dated 08-12-<br />
2004 (HSFE04-04-Q-800)<br />
297. FEMA Accessible Model Travel Trailer To be supplemented<br />
56
Procurement Specifications dated 04-21-<br />
2006 (with Accessible One Bedroom<br />
Travel Trailer Floor plan)<br />
298. “Important Information for Travel<br />
Trailer Occupants” FEMA brochure<br />
299. FEMA Model Travel Trailer<br />
Procurement Specifications Dated: July<br />
14, 2005<br />
300. Declaration of Kevin Souza, former<br />
Acting Deputy Director of Individual<br />
Assistance Division of FEMA<br />
301. “FEMA Storage Site<br />
Duties/Responsibilities”<br />
302. April 25, 2008 letter from FEMA to a<br />
THU occupant<br />
303. Summary of Test Results conducted by<br />
Weston Solutions, Inc. for the U.S. EPA<br />
304. Air Toxics, Ltd. Laboratory Narrative<br />
for samples submitted by Weston<br />
Solutions<br />
305. FEMA test results for <strong>formaldehyde</strong><br />
testing at FEMA THU staging areas<br />
during November 2005, December 2005,<br />
and January 2006<br />
306. FEMA Memorandum from May 31,<br />
2006 regarding Formaldehyde Air<br />
Sampling at the THU staging area in<br />
Purvis, Mississippi<br />
307. Email correspondence between FEMA<br />
and Government staff<br />
57<br />
PSC002350 –<br />
PSC002351<br />
PSC003049 –<br />
PSC003057<br />
PSC003058 –<br />
PSC003065<br />
PSC003092 –<br />
PSC003094<br />
PSC003397 –<br />
PSC003399<br />
PSC003407 –<br />
PSC003409<br />
PSC003410 –<br />
PSC003415<br />
PSC003416 –<br />
PSC003420<br />
PSC003421 –<br />
PSC003438<br />
PSC003439 –<br />
PSC003447<br />
308. FEMA Job Hazard Analysis Worksheet PSC023600<br />
309. FEMA Model Travel Trailer<br />
Procurement Specifications dated<br />
August 12, 2004<br />
310. New FEMA Procurement Specifications<br />
dated April 11, 2008 Release Number<br />
HQ-08-056<br />
311. FEMA Formaldehyde Timeline as of<br />
June 15, 2007<br />
312. FEMA Timeline as of August 7, 2008<br />
(From the deposition of Kevin Souza,<br />
FEMA Representative)<br />
313. FEMA Procedure Storage Site Manual<br />
Fall 2005<br />
FOREST-0002503 –<br />
FOREST-0002508<br />
PSC023601 –<br />
PSC023686<br />
PSC023687 –<br />
PSC023689<br />
PSC023690 –<br />
PSC023702<br />
To be supplemented
314. Dept of Homeland Security-Office of<br />
Inspector General-Hurricane Katrina<br />
Temporary Housing Technical<br />
Assistance Contracts- August 20, 2008<br />
(Internal Audit: OIG-08-88)<br />
315. FEMA Myths & Facts: Travel Trailers-<br />
November 8, 2007<br />
316. FEMA media release: Katrina/Rita<br />
Housing Facts-January 29, 2008<br />
317. FEMA media release: FEMA’s Ongoing<br />
Response to Formaldehyde-February 12,<br />
2008<br />
318. FEMA media release: CDC Results of<br />
Formaldehyde Level Tests- February 14,<br />
2008<br />
319. FEMA media release: FEMA Plan of<br />
Action on Formaldehyde Findings to be<br />
Implemented Immediately-February 14,<br />
2008<br />
320. FEMA media release: FEMA Offering<br />
Formaldehyde Testing to Occupants of<br />
Trailers and Mobile Homes in Disasters<br />
Nationwide-February 22, 2008<br />
321. FEMA media release: FAQ: 2008<br />
Disaster Housing Plan – June 10, 2008<br />
322. FEMA Statement on Formaldehyde –<br />
July 9, 2008<br />
323. FEMA media release: Myths & Facts<br />
about FEMA Housing Following<br />
Katrina-May 26, 2008<br />
324. FEMA media release: New Task<br />
Contract Awarded for Temporary<br />
Housing Units-August 4, 2008<br />
325. FEMA media release: Frequently Asked<br />
Questions-October 27, 2008<br />
326. FEMA media release: Initial Indoor Air<br />
Quality Tests Results-November 14,<br />
2008<br />
327. FEMA media release: FAQ National<br />
Disaster Housing Strategy – January 16,<br />
2009<br />
328. FEMA Statement on Travel Trailers and<br />
Formaldehyde<br />
58<br />
PSC023835 –<br />
PSC023863<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
PSC023795<br />
329. Email from Christopher DeRosa to PSC023796
Howard Frumkin on February 27, 2007<br />
330. Correspondence from Christopher<br />
DeRosa to Patrick Preston on February<br />
27, 2007<br />
331. Email from Christopher DeRosa to<br />
Howard Frumkin and Thomas Sinks on<br />
March 9, 2007<br />
332. Email from Christopher DeRosa to Mike<br />
Groutt on August 10, 2007<br />
333. Comments on Chro<strong>no</strong>logy of FEMA<br />
Trailers, drafted by Christopher DeRosa<br />
334. Correspondence from Christopher<br />
DeRosa to Howard Frumkin on<br />
September 21, 2007<br />
335. Email from Thomas Sinks to All CDC<br />
on October 12, 2007<br />
336. NCEH/ATSDR Procedures regarding<br />
Official Interaction with Persons or<br />
organization outside of NCEH/ATSDR<br />
59<br />
PSC023797<br />
PSC023798 –<br />
PSC023799<br />
PSC023800<br />
PSC023801<br />
PSC023802 –<br />
PSC023808<br />
PSC023809<br />
PSC023810 –<br />
PSC023811<br />
337. Logbook of Joseph Little To be supplemented<br />
338. Email from Patrick Preston to Scott To be supplemented<br />
Wright on November 30, 2005<br />
339. Email from Scott Wright and Joseph<br />
Little to Richard Nikel, et al., on<br />
December 7, 2006<br />
To be supplemented<br />
340. Correspondence between Barbara<br />
Rogers to Angela Davis and Sascha<br />
Fielding on March 21, 2007<br />
341. Email of Mary Margaret Walker<br />
(FEMA-WAXMAN-7-26-07 Production<br />
– 485)<br />
342. Correspondence From Mark Keim to<br />
Patrick Preston on March 17, 2007<br />
343. Correspondence from Patrick Preston to<br />
Scott Wright on November 30, 2005<br />
344. Email between Sam Coleman, Joseph<br />
Little and Scott Wright on December 1,<br />
2006<br />
345. Correspondence from Mark Keim to<br />
Patrick Preston on February 1, 2007<br />
346. Email to and from Philip Allred on<br />
February 15, 2007<br />
347. Email from Anne Sowell to Mark<br />
Bashor on August 8, 2007<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
PSC023819 –<br />
PSC023821<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented
348. Email between Patrick Preston and To be supplemented<br />
Margaret Ramos on February 27, 2007<br />
349. Email between David Chawaga and To be supplemented<br />
Mary Margaret Walker on May 1, 2007<br />
350. FEMA: Interim Direction on use of<br />
Temporary Housing Units (Revision<br />
PSC023828 –<br />
PSC023834<br />
Effective Date: March 10, 2008)<br />
. FEMA: FEMA Begins Next Phase of To be supplemented<br />
Inventory Reduction of Excess<br />
Temporary Housing Units<br />
352. “FEMA: Important Formaldehyde FEMA09-000388<br />
Information from FEMA Housing<br />
Occupants:<br />
353. “FEMA Travel Trailer Requirements” PSC0261671<br />
354. Any and all documents produced by Dr. To be supplemented<br />
Christopher DeRosa at his deposition,<br />
which will be taken/has been taken, or<br />
used as exhibits thereto<br />
355. Flyer: “CDC will test Trailers and To be supplemented<br />
Mobile Homes for Formaldehyde for<br />
CDC Partners such as Community<br />
Organizations in Louisiana and<br />
Mississippi” dated December 2007<br />
356. Script for Formaldehyde Concerns in To be supplemented<br />
Temporary Housing Unit: IA recipients<br />
with questions about <strong>formaldehyde</strong>, July<br />
2007<br />
357. Applicants Reporting MH/TT<br />
To be supplemented<br />
Formaldehyde Issues: IA recipients with<br />
questions about <strong>formaldehyde</strong>, July 2007<br />
358. Lottie Travel Trailer (Receiving) To be supplemented<br />
Inspection Checklist<br />
359. FEMA Brochure: “Important<br />
To be supplemented<br />
Information for Travel Trailer<br />
Occupants”<br />
360. FEMA: Important Formaldehyde To be supplemented<br />
Information for FEMA Housing<br />
Occupants<br />
361. Email from Martin McNeese dated To be supplemented<br />
October 11, 2006<br />
362. Email from Curtis Melnick dated May To be supplemented<br />
11, 2006<br />
363. Memo from FEMA Temporary Housing<br />
Agent Group: Occupants with questions<br />
To be supplemented<br />
60
about Formaldehyde regarding<br />
Formaldehyde-Help-line Calls, Referrals<br />
and Transfers dated July 2007<br />
364. FEMA Internal documents regarding<br />
<strong>formaldehyde</strong><br />
365. Emails regarding Katrina and Rita<br />
housing estimates dated November 1,<br />
2005<br />
366. Assessment of health Complaints among<br />
Pediatric Residents of FEMA-Supplied<br />
Trailers and Mobile Homes in Hancock<br />
County, Mississippi (Exhibit from the<br />
deposition of Michael Lapinski)<br />
367. Fact Sheet: Assessment of Health<br />
Complaints Among Children Living in<br />
FEMA Temporary Housing Units in<br />
Hancock county, Mississippi (Exhibit<br />
from the deposition of Michael<br />
Lapinski)<br />
Emails re: Formaldehyde<br />
Formaldehyde Flyer<br />
61<br />
To be supplemented<br />
To be supplemented<br />
Lapinski<br />
Exhibit 17<br />
Lapinski<br />
Exhibit 16<br />
To be supplemented<br />
To be supplemented<br />
Request for Proposal re: Travel Trailers FR 3522<br />
To be supplemented<br />
368. Any and all documentation and/or<br />
exhibits identified by defendant’s<br />
experts and/or fact witness in the<br />
preparation of their reports and/or<br />
testimony.<br />
369. Any and all exhibits identified and/or<br />
used and/or relied upon by defendant’s<br />
in the ongoing litigation of this matter.<br />
Shaw<br />
Billing records of all <strong>US</strong>A / FEMA<br />
Defense Experts<br />
Any photographs taken by <strong>US</strong>A / FEMA<br />
and/or <strong>US</strong>A / FEMA defense experts<br />
Any document to be identified by<br />
Defendant <strong>US</strong>A / FEMA in the ongoing<br />
discovery and deposition process<br />
Any <strong>US</strong>A / FEMA supplementation of<br />
any report and supplementing documents<br />
which may occur<br />
Any and all <strong>US</strong>A / FEMA demonstrative<br />
aids for trial to be exchanged at the<br />
appropriate time<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented
Environmen<br />
tal<br />
370. Any and all Class certification Shaw<br />
Environmental deposition testimony<br />
371. Any and all Class certification Shaw<br />
Environmental deposition exhibits /<br />
documents produced<br />
372. Shaw Environmental unit file on Lyndon<br />
Wright <strong>trailer</strong><br />
62<br />
To be supplemented<br />
To be supplemented<br />
SHAW WRI-00001-<br />
SHAW WRI-00017<br />
Entergy Orleans Meter Data SHAW-WRI 00051<br />
Shaw Standard Operating Procedure<br />
Trailer Processing and Yard Inspection<br />
dated 2/1/06<br />
SHAW 013564-<br />
SHAW 013568<br />
CH2M Hill, Inc., FEMA Trailer User’s SHAW 013523-<br />
Guide<br />
SHAW 013538<br />
373. Shaw / FEMA contract To be supplemented<br />
IA / TAC Contract SHAW 001890-<br />
SHAW 002019<br />
FEMA Request for Proposal Contract SHAW 000373<br />
HSFEHQ-05-0573<br />
SHAW 000578<br />
Checklists / PMI form SHAW 013303<br />
Picture of Installed Trailer SHAW 002517<br />
TT/MH QC Construction Issues/Maint SHAW 002363-<br />
Issues Sheet<br />
SHAW 002364<br />
Shaw Code emails and communications To be supplemented<br />
Orleans Parish Motion SHAW 002099-<br />
SHAW 003912<br />
Kenner Ordinance SHAW 003932-<br />
SHAW 003934<br />
Gretna & Westwego Ordinance SHAW 003930-<br />
SHAW 003931<br />
Communications with Subs re:<br />
implementation of Emergency Housing<br />
Contract (to be identified)<br />
C. Martin Documents (and other transfer<br />
documents)<br />
To be supplemented<br />
SHAW 000042-<br />
SHAW 000051;<br />
LW-CMC-000001-<br />
LW-CMC-000071<br />
Crown Roofing Services Documents CROWN 000001-<br />
CROWN 000016<br />
July 19, 2006 Work Plan SHAW 000669-<br />
SHAW 000700<br />
Pier Construction SHAW 002416<br />
Shaw Emails relating to Formaldehyde SHAW 013510;
SHAW 013511-<br />
SHAW 013512;<br />
SHAW 013513-<br />
SHAW 013514;<br />
SHAW 013515-<br />
SHAW013516;<br />
SHAW 013517-<br />
SHAW 013518;<br />
SHAW 013519-<br />
SHAW 013520;<br />
SHAW 013521-<br />
SHAW 013522;<br />
SHAW 013539-<br />
SHAW 013545;<br />
SHAW 013546-<br />
SHAW 013547;<br />
SHAW 013548-<br />
SHAW 013549;<br />
SHAW 013554;<br />
SHAW 013555-<br />
SHAW 013556;<br />
SHAW 013557;<br />
SHAW 013558-<br />
SHAW 013559;<br />
SHAW 013560-<br />
SHAW 013562<br />
Shaw Email: Burgess to Goetz, SHAW 002257-<br />
10/18/05<br />
SHAW 002259<br />
9:51 a.m.<br />
Shaw Email: Burgess to Goetz, 10/18/05<br />
2:48 p.m.<br />
SHAW 002260-<br />
SHAW 002263<br />
Shaw Email: Miller to Burgess, 11/29/05 SHAW 003145-<br />
SHAW 003147<br />
Shaw Email: Miller to Burgess, 11/22/05 SHAW 003058<br />
Shaw Email: Black to Janz, 11/11/05 SHAW 002773-<br />
SHAW 002796<br />
Shaw Email: Neal to Janz, 02/03/06 SHAW 005015-<br />
SHAW 005016<br />
Shaw Email: Orris to Brixius, 10/19/05 SHAW 002302-<br />
SHAW 002303<br />
Shaw Email: Janz to Smiley, 07/06/06 SHAW 011024-<br />
SHAW 011025<br />
Shaw Policies and Clarifications SHAW 002726-<br />
SHAW 002727<br />
63
Shaw Group Suggested Call Center<br />
Questionnaire<br />
SHAW 013236-<br />
SHAW 013237<br />
Haul & Install Call Center Questionnaire SHAW 013238-<br />
SHAW 013240<br />
Do Not Lease Document SHAW 003267<br />
Shaw Task Order 05-0006 Site SHAW 000601-<br />
Identification<br />
SHAW 000615<br />
Shaw Task Order No. 014 Trailer<br />
Transportation<br />
SHAW 000631-<br />
SHAW 000632<br />
Final Draft Work Order, March 19, 2006 SHAW 000900-<br />
SHAW 000939<br />
Final Group Site Work Plan, April 2006 SHAW 000952-<br />
SHAW 000992<br />
June 8, 2006, Work Plan SHAW 000746-<br />
SHAW 000786<br />
June 14, 2006 City Park Trailer Park SHAW 001054-<br />
SHAW 001089<br />
Final Work Order on Group Sites, June<br />
26, 2006<br />
SHAW 001102-<br />
SHAW 001142<br />
Shaw Inspection Protocol (2 pages) To be supplemented<br />
Demobilization Documents SHAW 002316-<br />
SHAW 002317<br />
374. All FEMA task orders to Shaw To be supplemented<br />
Environmental<br />
375. All FEMA extension of time orders to To be supplemented<br />
Shaw Environmental<br />
All <strong>formaldehyde</strong> emails and documents To be supplemented<br />
RCG Contract Documents<br />
376. All FEMA Amendments or<br />
Modifications to Shaw Environmental<br />
contract<br />
64<br />
To be supplemented<br />
To be supplemented<br />
377. All Shaw Environmental work plans To be supplemented<br />
produced to Plaintiff<br />
378. Subcontractor agreement with installer To be supplemented<br />
of Wright unit<br />
379. Affidavits of John D. Osteraas To be supplemented<br />
380. Curriculum Vitae of John D. Osteraas To be supplemented<br />
381. Reliance Materials and File of John D. To be supplemented<br />
Osteraas<br />
382. Any and all Deposition Testimony of To be supplemented<br />
John D. Osteraas<br />
383. Any and all Exhibits from the To be supplemented<br />
deposition(s) of John D. Osteraas<br />
384. Any and all Deposition Testimony of To be supplemented
Corporate Representative of Shaw<br />
Environmental, yet to be designated<br />
385. Any and all Exhibits from the<br />
deposition(s) of Corporate<br />
Representative of Shaw Environmental,<br />
yet to be designated<br />
386. Any and all Deposition Testimony of<br />
Project Manager of Shaw<br />
Environmental, yet to be designated<br />
387. Any and all Exhibits from the<br />
deposition(s) of Project Manager of<br />
Shaw Environmental, yet to be<br />
designated<br />
388. Any and all additional documents <strong>no</strong>t yet<br />
produced in this matter<br />
389. Any and all documentation and/or<br />
exhibits identified by defendant’s<br />
experts and/or fact witness in the<br />
preparation of their reports and/or<br />
testimony.<br />
390. Any and all exhibits identified and/or<br />
used and/or relied upon by defendant’s<br />
in the ongoing litigation of this matter.<br />
Billing records of all Shaw<br />
Environmental Defense Experts<br />
Any photographs taken by Shaw<br />
Environmental and/or Shaw<br />
Environmental defense experts<br />
Any Shaw Environmental<br />
supplementation of any report and<br />
supplementing documents which may<br />
occur<br />
Any document to be identified by<br />
Defendant Shaw Environmental in the<br />
ongoing discovery and deposition<br />
process<br />
Any and all Shaw Environmental<br />
demonstrative aids for trial to be<br />
exchanged at the appropriate time<br />
Wright Unit<br />
391. Photographs taken by or in the<br />
possession of Wright of the Forest River,<br />
Inc., unit<br />
Photographs of Lyndon Wright with<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
65
Trailer<br />
392. Any and all labels or stickers on the<br />
Forest River, Inc., unit occupied by<br />
Lyndon Wright<br />
Billing records of all Shaw<br />
Environmental Defense Experts<br />
All photographs taken by Shaw<br />
Environmental<br />
Wright File<br />
393. Photographs of Lyndon Wright<br />
regarding skin conditions<br />
66<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
394. Lyndon Wright Financial Records To be supplemented<br />
395. Lyndon Wright Employment Records To be supplemented<br />
Employment Records from the City of<br />
New Orleans related to Lyndon Wright<br />
LW-CITY NO00001-<br />
00256<br />
Attendance Records from City of New<br />
Orleans and Hyatt New Orleans relating<br />
to Lyndon Wright<br />
LW-CITY NO 00001-<br />
00256 & LW-<br />
HYATT00001-00126<br />
Lyndon Wright Original Complaint<br />
Lyndon Wright Amended Complaint<br />
Lyndon Wright Plaintiff Fact Sheet<br />
Lyndon Wright Amended Plaintiff Fact<br />
Sheet<br />
Medical<br />
Records<br />
396. Medical Records from Dr. Farber,<br />
Kenner Dermatology / Gulf South<br />
Medical and Surgical Institute regarding<br />
Lyndon Wright<br />
Photographs of Lyndon Wright from the<br />
records of Kenner Dermatology<br />
Medical Records from East Jefferson<br />
General Hospital regarding Lyndon<br />
Wright<br />
397. Medical Records from Dr. Worley<br />
regarding Lyndon Wright<br />
398. Medical Records from Uptown<br />
Nephrology regarding Lyndon Wright<br />
399. Medical Records from Dr. Richard<br />
Spector regarding Lyndon Wright<br />
Medical Records from Dr. Kenneth<br />
Smith regarding Lyndon Wright<br />
Medical Records of Dr. H. James<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
LWFR-EXP2-000021-<br />
LWFR-EXP2-000052<br />
LWFR-EXP2-000010-<br />
LWFR-EXP2-000020<br />
LWFR-EXP15-000518-<br />
LWFR-EXP15-000522;<br />
LW-EJGH0001-<br />
LW-EJGH00041<br />
LWFR-EXP14-000255-<br />
LWFR-EXP14-000256<br />
LWFW-EXP14-000085-<br />
LWFW-EXP14-000254<br />
LWFR-EXP14-000008-<br />
LWFR-EXP14-000084<br />
LTW-EXP07-000250<br />
LTW-EXP07-000291<br />
To be supplemented
Wedner<br />
Touro Medical Records<br />
Dr. Shwery administered psychological<br />
testing data<br />
Dr. Thompson / Dr. Mangu<strong>no</strong>-Mire<br />
psychological testing<br />
Report of Gina Mangu<strong>no</strong>-Mire<br />
400. Rite Aid Pharmacy Records regarding<br />
Lyndon Wright<br />
Walgreens Pharmacy Records regarding<br />
Lyndon Wright<br />
Others<br />
Demonstrative wood panels removed<br />
from the Lyndon Wright Trailer<br />
Demonstrative Samples of No<br />
Formaldehyde Added wood composite<br />
products<br />
401. Any and all Deposition Testimony of<br />
Representative of NACS, yet to be<br />
designated<br />
402. Any and all Exhibits from the<br />
deposition(s) of Representative of<br />
NACS, yet to be designated<br />
403. Any and all Deposition Testimony of<br />
Representative of RVIA, yet to be<br />
designated<br />
404. Any and all Exhibits from the<br />
deposition(s) of Representative of<br />
RVIA, yet to be designated<br />
Any and all Deposition Testimony of<br />
Representative of Lippert Components,<br />
yet to be designated<br />
Any and all Exhibits from the<br />
deposition(s) of Representative of<br />
LWFR-EXP12-000040-<br />
LWFR-EXP12-000046;<br />
LWFR-EXP12-000150-<br />
LWFR-EXP12-000153<br />
LWFR-EXP12-000289-<br />
LWFR-EXP12-000312;<br />
LWFR-EXP12-000512-<br />
LWFR-EXP12-000519<br />
FR-LTW-EXP08-<br />
002224-<br />
FR-LTW-EXP08-002258<br />
To be supplemented<br />
FR-LTW-EXP08-<br />
002259-<br />
FR-LTW-EXP08-002261<br />
LWFR-EXP12-000279-<br />
LWFR-EXP12-000286<br />
LWFR-EXP12-000485-<br />
LWFR-EXP12-000509<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
67
Lippert Components, yet to be<br />
designated<br />
Any and all Deposition Testimony of<br />
Representative of RCG Enterprises, yet<br />
to be designated<br />
Any and all Exhibits from the<br />
deposition(s) of Representative of RCG<br />
Enterprises, yet to be designated<br />
Louisiana State Board of Medical<br />
Examiners Temporary Permit<br />
Qualifications/Instructions<br />
BlueLinx Corporation: Material Safety<br />
Data Sheet for urea Formaldehyde<br />
Bonded Wood Products<br />
Georgia-Pacific: Material Safety Data<br />
Sheet for Urea Formaldehyde Bonded<br />
Wood Products<br />
Louisiana Pacific: Material Safety Data<br />
Sheet for Urea Formaldehyde Bonded<br />
Panel Products<br />
Lippert Component Frame Design for<br />
32BHLE units<br />
Georgia Pacific: Material Safety Data<br />
Sheet #30 for UF Bonded Wood<br />
Products<br />
Georgia Pacific: Material Safety Data<br />
Sheet #31 for Wood and Wood Products<br />
Manufactured Home Decking Labels<br />
from Georgia Pacific<br />
City of New Orleans Environmental<br />
testing results and report responsive to<br />
Forest River, Inc., subpoena<br />
Any photographs and/or videos taken by<br />
Scott Johnson of the Testing of the<br />
Forest River Unit<br />
Any and all documentation and/or<br />
exhibits identified by defendant’s<br />
experts and/or fact witness in the<br />
preparation of their reports and/or<br />
testimony.<br />
Any document necessary for rebuttal<br />
Any and all exhibits and/or documents<br />
identified and/or used and/or relied upon<br />
by defendant’s in the ongoing litigation<br />
To be supplemented<br />
To be supplemented<br />
PSC026167 –<br />
PSC026172<br />
PSC003068 –<br />
PSC003078<br />
PSC003079 –<br />
PSC003091<br />
FLE00006354<br />
To be supplemented<br />
GAPAC-000001 –<br />
GAPAC-000006<br />
GAPAC-000007 –<br />
GAPAC-000011<br />
GAPAC-000012 –<br />
GAPAC-000014<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
To be supplemented<br />
68
of this matter.<br />
Any and all deposition testimony and/or<br />
documents or exhibits introduced at any<br />
deposition of plaintiff’s and/or<br />
defendants’ experts<br />
Any and all plaintiff and/or defendants<br />
expert reports, both preliminary and<br />
final, submitted and anticipated to be<br />
submitted including all reliance<br />
materials.<br />
To be supplemented<br />
To be supplemented<br />
Plaintiff respectfully reserves the right to utilize any exhibit listed by any other party or<br />
utilized as an exhibit in the depositions taken in this matter. Plaintiff further respectfully<br />
reserves the right to supplement and amend this list once discovery is complete.<br />
CERTIFICATE OF SERVICE<br />
RESPECTFULLY SUBMITTED:<br />
FRANK J. D’AMICO, JR., APLC<br />
BY: s/Frank J. D’Amico, Jr.<br />
FRANK J. D’AMICO, JR., T.A. (#17519)<br />
AARON Z. AHLQUIST (#29063)<br />
FRANK J. D’AMICO, JR., APLC<br />
622 Baronne Street<br />
New Orleans, LA 70113<br />
Telephone: (504) 525-7272<br />
Fax: (504) 525-952<br />
I hereby certify that on January 12, 2010, I electronically filed the foregoing with the<br />
Clerk of <strong>Court</strong> by using the CM/ECF system which will send a <strong>no</strong>tice of electronic filing to all<br />
counsel of record who are CM/ECF participants. I further certify that I mailed the foregoing<br />
document and the <strong>no</strong>tice of electronic filing by first-class mail to all counsel of record who are<br />
<strong>no</strong>n-CM/ECF participants.<br />
s/Frank J. D’Amico<br />
FRANK J. D’AMICO, #17519<br />
69